48 results on '"Vitcu, A."'
Search Results
2. Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization
- Author
-
Lenzen, M. J., Boersma, E., Bertrand, M. E., Maier, W., Moris, C., Piscione, F., Sechtem, U., Stahle, E., Widimsky, P., De Jaegere, P., Scholte Op Reimer, W. J. M., Mercado, N., Wijns, W., Meier, B., Sergeant, P., Vos, J., Unger, F., Manini, Malika, Bramley, Claire, Laforest, Valérie, Taylor, Charles, Del Gaiso, Susan, Huber, Kurt, De Backer, Guy, Sirakova, Vera, Cerbak, Roman, Thayssen, Per, Lehto, Seppo, Blanc, Jean-Jacques, Delahaye, François, Kobulia, Bondo, Zeymer, Uwe, Cokkinos, Dennis, Karlocai, Kristof, Graham, Ian, Shelley, Emer, Behar, Shlomo, Maggioni, Aldo, Grabauskiene, Virginija, Deckers, Jaap, Asmussen, Inger, Stepinska, Janina, Gonçalves, Lino, Mareev, Vyacheslav, Riecansky, Igor, Kenda, Miran F., Alonso, Angeles, Lopez-Sendon, José Luis, Rosengren, Annika, Buser, Peter, Okay, Tugrul, Sychov, Oleg, Fox, Kevin, Wood, David, Boersma, Eric, Crijns, Harry, Fox, Kim, McGregor, Keith, Mulder, Barbara, Priori, Sylvia, Rydén, Lars, Tavazzi, Luigi, Vahanian, Alec, Vardas, Panos, Wijns, William, Sarkisyan, Karine, Glogar, H. D., Derntl, Michael, Frick, Matthias, Pachinger, O., Zwick, Ralf, Vrints, Christiaan, Van Hertbruggen, Els, Vercammen, Marc, Sysmans, Tineke, Schroeder, E., Domange, Juliette, De Pril, Hilde, De Vriese, Johan, Van Hecke, Tonny, Legrand, V., Gillon, Marie-France, Richardy, Michel, Doneux, P., Petrov, Ivo, Jorgova, J., Starcevic, Boris, Eeckhout, Eric, Berger, Alexandre, Prudent, Veronique, Camenzind, E., Masson, Nicolas, Zambartas, Costas, Kleanthous, Helen, Widimsky, Petr, Stellova, Blanka, Aschermann, Michael, Simek, Stanislav, Kautzner, J., Karmazin, Vladimir, Svab, P., Indrak, Jan, Branny, M., Hladilova, Kveta, Kala, P., Thayssen, P., Cappelen, Helle, Jensen, Lisette Okkels, Gitt, A., Gehrke, Konstanze, Erbel, R., Gutersohn, Achim, Eggebrecht, Holger, Al Khani, Murad, Sechtem, Udo, Rosenberger, Antje, Vogelsberg, Holger, Klepzig, H., Schmidt, Arnold, Silber, Sigmund, Mau, Birgit, Leuner, Christian, Czyborra, Karen, Reuschling, Christina, Muno, Eva, Kleber, F., Rux, Sascha, Zeymer, U., Saad, Aly, Ibrahim, B. S. S., Elabady, Maged, Castro Beiras, A., Fernandez, Jorge Salgado, Navarro Del Arno, Felipe, Iniguez Romo, A., Cruz Fernandez, J. M., Mayoreal, Alejandro Recio, Rebanal, Franciso Javier Rivero, De La Borbolla, Mariano Garcia, Chaparro, Marinela, Brotons, C., Permanyer Miralda, C., Vilai Perez, Srta Irma, Moris, Cesar, Fernandez Aviles, F., De La Fuente Galan, Luis, Vinuela, Paula Tejedor, Malpartida De Torres, F., Mora, Javier, Rodriguez, Ignacio Santos, Bustamante, Itziar Piedra, Sanchez Fernandez, Pedro L., Diago Torrent, J. L., Diez Gil, Jose L., Perpinan, Javier, Palacios Motilla, V., Soledad Alcasena Juango, M., Berjon-Reyero, Jesus, Melgares Moreno, R., Guerrero, Juan Carlos Fernandez, Lehto, S., Savolainen, Kirsti, Nieminen, M. S., Syvanne, Mikko, Cohen-Solal, A., Oboa, Antoine-Sylvain, Bassand, J. P., Espinosa, Denis Pales, Jouet, Veronique, Montalescot, G., Gallois, Vanessa, Daubert, J. C., Clerc, Jean Michel, Machecourt, Jacques, Cottin, Y., Walker, D., Holland, Fhiona, Wood, D., Prosser, Jenni, Muir, Lis, Barber, Kate, Cleland, J. G. F., Cook, Jocelyn, Chapichadze, Zaza, Christos, Ioannis Skoularigisn Athanasiou, Tsiavou, Nastasia, Chrysohoou, Christina, Manginas, Athanassios, Terrovitis, John, Kanakakis, John, Vavuranakis, Manolis, Drakos, Stavros, Farmakis, Thomas, Samara, C., Papakosta, Christina, Bourantas, Christos, Michalis, L. K., Christos, Mpourantas, Foussas, Stefanos, Adamopoulou, Evdokia, Vardas, P. E., Marketou, Mary, Alotti, N., Basa, Anna Maria, Vigh, Andras, Preda, Istvan, Csoti, Eva, Keltai, M., Kerkovits, G., Hendler, Alberto, Blatt, Alex, Beyar, R., Shefer, Arie, Halon, David, Bentzvi, Margalait, Avramovitch, Naomi, Bakst, Avinoam, Cafri, Carlos, Grosbard, Aviva, Margolis, Bella, Suleiman, Khalid, Banai, Shmuel, Meerkin, David, Mosseri, Morris, Guita, Pnina, Jabara, Rifat, Jafari, Jamal, Ben Shitrit, Debi, Ghasan, null, Salameh, null, Brezins, Marc, Van Den Akker-Berman, Lily, Guetta, Victor, Rozenman, Yoseph, Biagini, A., Berti, Sergio, Ferrero, Massimo, Colombo, A., Roccaforte, R., Milici, Caterina, Scarpino, L., Salvi, A., Desideri, Alessandro, Sabbadin, Daniela, Galassi, Alfredo, Giuffrida, Giuseppe, Rognoni, Andrea, Vassanelli, Corrado, Paffoni, Paola, Cioppa, Angelo, Rubino, Paolo, De Carlo, Marco, Petronio, Anna Sonia, Naccarella, F., Saia, Francesco, Marzocchi, Antonio, Maranga, Stefano Sdringola, Presbitero, P., Valsecchi, Fazya, Piscione, Federico, Esposito, Giovanni, Santini, Napoli M., Tubaro, Marco, Erglis, A., Narbute, Inga, Kavoliuniene, Ausra, Zaliunas, R., Navickas, Ramunas, Grabauskiene, V., Luckute, Davia, Subkovas, Eduardas, Wagner, Daniel, Vermeer, F., Lousberg, Aimee, Fransen, Heidi, Breeman, Arno, Tebbe, Henriette, De Boer, M. J., Van Der Wal, Metske, Deckers, J., Vos, Jeroen, Leenders, C. M., Veerhoek, M. J., Jansen, Chris, Bijl, M., Koppelaar, Colinda, Van Den Linden, null, Brons, R., Widdershofen, J. W. M. G., Broers, Herman, Kontny, F., Jonzon, Marianne, Wodniecki, Jan, Tomasik, Andrzej, Trusz-Gluza, M., Nowak, Seweryn, Ruzyllo, Witold, Deptuch, Tomasz, Marques, Jorge, Matias, F., Madeira, H., Oliveira, Joaquim, Sargento, Luis, Ionac, Adina, Dragulescu, Iosif Stefan, Mut-Vitcu, Bogdan, Maximov, Daniela, Dorobantu, M., Apetrei, E., Niculescu, Rodica, Petrescu, Virgil, Bucsa, Adrian, Deleanu, Dan, Benedek, I. S., Hintea, Theodora, Aronov, D., Tikhomirova, Elena, Kranjec, I., Prokselj, Katja, Kanic, Vojko, Sepetoglu, Ahmet, Aytekin, S., Aytekin, V., Catakoglu, Alp Burak, Parlar, Hayri, Tufekcioglu, Suavi, Ozyedek, Zeki, Baltali, Mehmet, Kiziltan, null, Vukovic, Milan, Neskovic, A. N., Lenzen, M. J, Boersma, E, Bertrand, Me, Maier, W, Moris, C, Esposito, Giovanni, Piscione, Federico, Sechtem, U, Stahle, E, Widimsky, P, de Jaegere, P, Scholte op Reimer, W. J. M, Mercado, N, Wijns, W., University of Zurich, Wijns, W, Lenzen, M. J., Boersma, E., Bertrand, M. E., Maier, W., Moris, C., Piscione, F., Sechtem, U., Stahle, E., Widimsky, P., De Jaegere, P., Scholte Op Reimer, W. J. M., Mercado, N., Meier, B., Sergeant, P., Vos, J., Unger, F., Manini, Malika, Bramley, Claire, Laforest, Valérie, Taylor, Charle, Del Gaiso, Susan, Huber, Kurt, De Backer, Guy, Sirakova, Vera, Cerbak, Roman, Thayssen, Per, Lehto, Seppo, Blanc, Jean-Jacque, Delahaye, Françoi, Kobulia, Bondo, Zeymer, Uwe, Cokkinos, Denni, Karlocai, Kristof, Graham, Ian, Shelley, Emer, Behar, Shlomo, Maggioni, Aldo, Grabauskiene, Virginija, Deckers, Jaap, Asmussen, Inger, Stepinska, Janina, Gonçalves, Lino, Mareev, Vyacheslav, Riecansky, Igor, Kenda, Miran F., Alonso, Angele, Lopez-Sendon, José Lui, Rosengren, Annika, Buser, Peter, Okay, Tugrul, Sychov, Oleg, Fox, Kevin, Wood, David, Boersma, Eric, Crijns, Harry, Fox, Kim, Mcgregor, Keith, Mulder, Barbara, Priori, Sylvia, Rydén, Lar, Tavazzi, Luigi, Vahanian, Alec, Vardas, Pano, Wijns, William, Sarkisyan, Karine, Glogar, H. D., Derntl, Michael, Frick, Matthia, Pachinger, O., Zwick, Ralf, Vrints, Christiaan, Van Hertbruggen, El, Vercammen, Marc, Sysmans, Tineke, Schroeder, E., Domange, Juliette, De Pril, Hilde, De Vriese, Johan, Van Hecke, Tonny, Legrand, V., Gillon, Marie-France, Richardy, Michel, Doneux, P., Petrov, Ivo, Jorgova, J., Starcevic, Bori, Eeckhout, Eric, Berger, Alexandre, Prudent, Veronique, Camenzind, E., Masson, Nicola, Zambartas, Costa, Kleanthous, Helen, Widimsky, Petr, Stellova, Blanka, Aschermann, Michael, Simek, Stanislav, Kautzner, J., Karmazin, Vladimir, Svab, P., Indrak, Jan, Branny, M., Hladilova, Kveta, Kala, P., Thayssen, P., Cappelen, Helle, Jensen, Lisette Okkel, Gitt, A., Gehrke, Konstanze, Erbel, R., Gutersohn, Achim, Eggebrecht, Holger, Al Khani, Murad, Sechtem, Udo, Rosenberger, Antje, Vogelsberg, Holger, Klepzig, H., Schmidt, Arnold, Silber, Sigmund, Mau, Birgit, Leuner, Christian, Czyborra, Karen, Reuschling, Christina, Muno, Eva, Kleber, F., Rux, Sascha, Zeymer, U., Saad, Aly, Ibrahim, B. S. S., Elabady, Maged, Castro Beiras, A., Fernandez, Jorge Salgado, Navarro Del Arno, Felipe, Iniguez Romo, A., Cruz Fernandez, J. M., Mayoreal, Alejandro Recio, Rebanal, Franciso Javier Rivero, De La Borbolla, Mariano Garcia, Chaparro, Marinela, Brotons, C., Permanyer Miralda, C., Vilai Perez, Srta Irma, Moris, Cesar, Fernandez Aviles, F., De La Fuente Galan, Lui, Vinuela, Paula Tejedor, Malpartida De Torres, F., Mora, Javier, Rodriguez, Ignacio Santo, Bustamante, Itziar Piedra, Sanchez Fernandez, Pedro L., Diago Torrent, J. L., Diez Gil, Jose L., Perpinan, Javier, Palacios Motilla, V., Soledad Alcasena Juango, M., Berjon-Reyero, Jesu, Melgares Moreno, R., Guerrero, Juan Carlos Fernandez, Lehto, S., Savolainen, Kirsti, Nieminen, M. S., Syvanne, Mikko, Cohen-Solal, A., Oboa, Antoine-Sylvain, Bassand, J. P., Espinosa, Denis Pale, Jouet, Veronique, Montalescot, G., Gallois, Vanessa, Daubert, J. C., Clerc, Jean Michel, Machecourt, Jacque, Cottin, Y., Walker, D., Holland, Fhiona, Wood, D., Prosser, Jenni, Muir, Li, Barber, Kate, Cleland, J. G. F., Cook, Jocelyn, Chapichadze, Zaza, Christos, Ioannis Skoularigisn Athanasiou, Tsiavou, Nastasia, Chrysohoou, Christina, Manginas, Athanassio, Terrovitis, John, Kanakakis, John, Vavuranakis, Manoli, Drakos, Stavro, Farmakis, Thoma, Samara, C., Papakosta, Christina, Bourantas, Christo, Michalis, L. K., Christos, Mpouranta, Foussas, Stefano, Adamopoulou, Evdokia, Vardas, P. E., Marketou, Mary, Alotti, N., Basa, Anna Maria, Vigh, Andra, Preda, Istvan, Csoti, Eva, Keltai, M., Kerkovits, G., Hendler, Alberto, Blatt, Alex, Beyar, R., Shefer, Arie, Halon, David, Bentzvi, Margalait, Avramovitch, Naomi, Bakst, Avinoam, Cafri, Carlo, Grosbard, Aviva, Margolis, Bella, Suleiman, Khalid, Banai, Shmuel, Meerkin, David, Mosseri, Morri, Guita, Pnina, Jabara, Rifat, Jafari, Jamal, Ben Shitrit, Debi, Ghasan, Null, Salameh, Null, Brezins, Marc, Van Den Akker-Berman, Lily, Guetta, Victor, Rozenman, Yoseph, Biagini, A., Berti, Sergio, Ferrero, Massimo, Colombo, A., Roccaforte, R., Milici, Caterina, Scarpino, L., Salvi, A., Desideri, Alessandro, Sabbadin, Daniela, Galassi, Alfredo, Giuffrida, Giuseppe, Rognoni, Andrea, Vassanelli, Corrado, Paffoni, Paola, Cioppa, Angelo, Rubino, Paolo, De Carlo, Marco, Petronio, Anna Sonia, Naccarella, F., Saia, Francesco, Marzocchi, Antonio, Maranga, Stefano Sdringola, Presbitero, P., Valsecchi, Fazya, Santini, Napoli M., Tubaro, Marco, Erglis, A., Narbute, Inga, Kavoliuniene, Ausra, Zaliunas, R., Navickas, Ramuna, Grabauskiene, V., Luckute, Davia, Subkovas, Eduarda, Wagner, Daniel, Vermeer, F., Lousberg, Aimee, Fransen, Heidi, Breeman, Arno, Tebbe, Henriette, De Boer, M. J., Van Der Wal, Metske, Deckers, J., Vos, Jeroen, Leenders, C. M., Veerhoek, M. J., Jansen, Chri, Bijl, M., Koppelaar, Colinda, Van Den Linden, Null, Brons, R., Widdershofen, J. W. M. G., Broers, Herman, Kontny, F., Jonzon, Marianne, Wodniecki, Jan, Tomasik, Andrzej, Trusz-Gluza, M., Nowak, Seweryn, Ruzyllo, Witold, Deptuch, Tomasz, Marques, Jorge, Matias, F., Madeira, H., Oliveira, Joaquim, Sargento, Lui, Ionac, Adina, Dragulescu, Iosif Stefan, Mut-Vitcu, Bogdan, Maximov, Daniela, Dorobantu, M., Apetrei, E., Niculescu, Rodica, Petrescu, Virgil, Bucsa, Adrian, Deleanu, Dan, Benedek, I. S., Hintea, Theodora, Aronov, D., Tikhomirova, Elena, Kranjec, I., Prokselj, Katja, Kanic, Vojko, Sepetoglu, Ahmet, Aytekin, S., Aytekin, V., Catakoglu, Alp Burak, Parlar, Hayri, Tufekcioglu, Suavi, Ozyedek, Zeki, Baltali, Mehmet, Kiziltan, Null, Vukovic, Milan, Neskovic, A. N., Cardiology, Lenzen, Mj, and Scholte op Reimer, Wj
- Subjects
Practice survey ,Male ,Coronary Stenosi ,Coronary angiography ,medicine.medical_treatment ,Myocardial Infarction ,Coronary Artery Disease ,Angina ,Coronary artery disease ,Myocardial Revascularization ,Stent ,Myocardial infarction ,Coronary Artery Bypass ,Angioplasty, Balloon, Coronary ,CABG ,PCI ,Professional Practice ,Health Survey ,Middle Aged ,Europe ,Treatment Outcome ,Epidemiologic Method ,Practice Guidelines as Topic ,Cardiology ,Stents ,Female ,Guideline Adherence ,Cardiology and Cardiovascular Medicine ,Human ,medicine.medical_specialty ,outcome ,Euro Heart Survey ,610 Medicine & health ,Platelet Glycoprotein GPIIb-IIIa Complex ,142-005 142-005 ,2705 Cardiology and Cardiovascular Medicine ,Angioplasty ,Internal medicine ,medicine ,Humans ,Angina, Unstable ,cardiovascular diseases ,Interventional cardiology ,Unstable angina ,business.industry ,Coronary Artery Bypa ,Coronary Stenosis ,Percutaneous coronary intervention ,Length of Stay ,medicine.disease ,Health Surveys ,Conventional PCI ,570 Life sciences ,biology ,Epidemiologic Methods ,business - Abstract
AIMS: The purpose of the Euro Heart Survey Programme of the European Society of Cardiology is to evaluate to which extent clinical practice endorses existing guidelines as well as to identify differences in population profiles, patient management, and outcome across Europe. The current survey focuses on the invasive diagnosis and treatment of patients with established coronary artery disease (CAD). METHODS AND RESULTS: Between November 2001 and March 2002, 7769 consecutive patients undergoing invasive evaluation at 130 hospitals (31 countries) were screened for the presence of one or more coronary stenosis >50% in diameter. Patient demographics and comorbidity, clinical presentation, invasive parameters, treatment options, and procedural techniques were prospectively entered in an electronic database (550 variables+29 per diseased coronary segment). Major adverse cardiac events (MACE) were evaluated at 30 days and 1 year. Out of 5619 patients with angiographically proven coronary stenosis (72% of screened population), 53% presented with stable angina while ST elevation myocardial infarction (STEMI) was the indication for coronary angiography in 16% and non-ST segment elevation myocardial infarction or unstable angina in 30%. Only medical therapy was continued in 21%, whereas mechanical revascularization was performed in the remainder [percutaneous coronary intervention (PCI) in 58% and coronary artery bypass grafting (CABG) in 21%]. Patients referred for PCI were younger, were more active, had a lower risk profile, and had less comorbid conditions. CABG was performed mostly in patients with left main lesions (21%), two- (25%), or three-vessel disease (67%) with 4.1 diseased segments, on average. Single-vessel PCI was performed in 82% of patients with either single- (45%), two- (33%), or three-vessel disease (21%). Stents were used in 75% of attempted lesions, with a large variation between sites. Direct PCI for STEMI was performed in 410 cases, representing 7% of the entire workload in the participating catheterization laboratories. Time delay was within 90 min in 76% of direct PCI cases. In keeping with the recommendations of practice guidelines, the survey identified under-use of adjunctive medication (GP IIb/IIIa receptor blockers, statins, and angiotensin-converting enzyme-inhibitors). Mortality rates at 30 days and 1 year were low in all subgroups. MACE primarily consisted of repeat PCI (12%). CONCLUSION: The current Euro Heart Survey on coronary revascularization was performed in the era of bare metal stenting and provides a global European picture of the invasive approach to patients with CAD. These data will serve as a benchmark for the future evaluation of the impact of drug-eluting stents on the practice of interventional cardiology and bypass surgery.
- Published
- 2005
3. Depression influences the quality of diabetes-related self-management activities in elderly patients with type 2 diabetes: a cross-sectional study
- Author
-
Cristian Oancea, Bogdan Timar, Gabriela Mut-Vitcu, Ioan Cosmin Citu, and Romulus Timar
- Subjects
Male ,medicine.medical_specialty ,Cross-sectional study ,media_common.quotation_subject ,030209 endocrinology & metabolism ,Type 2 diabetes ,Severity of Illness Index ,Diabetes Complications ,03 medical and health sciences ,0302 clinical medicine ,Quality of life (healthcare) ,Diabetes mellitus ,Surveys and Questionnaires ,self-care ,Medicine ,Humans ,Quality (business) ,030212 general & internal medicine ,Exercise ,Depression (differential diagnoses) ,media_common ,Aged ,Original Research ,Aged, 80 and over ,Psychiatric Status Rating Scales ,Self-management ,diabetes ,business.industry ,Depression ,Romania ,General Medicine ,Middle Aged ,medicine.disease ,Self Care ,Cross-Sectional Studies ,Logistic Models ,Diabetes Mellitus, Type 2 ,quality of life ,Clinical Interventions in Aging ,Multivariate Analysis ,Self care ,Physical therapy ,Female ,Geriatrics and Gerontology ,business - Abstract
Gabriela Mut-Vitcu,1 Bogdan Timar,2 Romulus Timar,1 Cristian Oancea,3 Ioan Cosmin Citu4 1Second Department of Internal Medicine, 2Department of Functional Sciences, 3Department of Infectious Diseases, 4Department of Obstetrics and Gynecology, “Victor Babes” University of Medicine and Pharmacy, Timisoara, Romania Purpose: To evaluate the prevalence of depression and its impact on the quality of diabetes-related self-care activities in elderly patients with type 2 diabetes. Patients and methods: In this cross-sectional study, 184 patients with type 2 diabetes were enrolled. Depression was evaluated using Patient Health Questionnaire-9 while the quality of diabetes-related self-care activities was assessed using the Summary of Diabetes-Related Self Care Activities Questionnaire. Results: In our study group, 53.3% of the patients had moderate depression, 17.9% had severe depression, and 28.8% had no depression symptoms. Patient’s age (P=0.024), presence of diabetic neuropathy (P
- Published
- 2016
4. Whole-Body Distribution and Radiation Dosimetry of 11C-(+)-PHNO, a D2/3 Agonist Ligand
- Author
-
Alvina Ng, Alan A. Wilson, Peter M. Bloomfield, Pablo Rusjan, Romina Mizrahi, Irina Vitcu, and Sylvain Houle
- Subjects
Adult ,Male ,Agonist ,Adult male ,medicine.drug_class ,Radiation ,Ligands ,Effective dose (radiation) ,Oxazines ,medicine ,Humans ,Dosimetry ,Tissue Distribution ,Radiology, Nuclear Medicine and imaging ,Radiometry ,Receptors, Dopamine D2 ,business.industry ,Receptors, Dopamine D3 ,Healthy subjects ,Internal radiation ,Organ Size ,Positron-Emission Tomography ,Dopamine Agonists ,Female ,Whole body ,Nuclear medicine ,business - Abstract
Using PET, we measured the whole-body distribution of 11C-(+)-PHNO (11C-(+)-4-propyl-9-hydroxynaphthoxazine), a D2/3 agonist, as a function of time in adult subjects in order to determine the internal radiation dose. Methods: PET whole-body data were acquired after the injection of 11C-(+)-PHNO (∼360 MBq) in 6 healthy subjects (3 male and 3 female). The PET acquisition duration was a maximum of 112.5 min, and 9 discrete time frames were obtained. After reconstruction of the emission data, 6 organs were identified in the images as exhibiting uptake above background levels. Regions of interest were delineated on these organs, and time–activity curves were generated. The time–activity curve data were corrected for the injected activity, specific organ density, and volume, from which normalized accumulated activities (previously known as residence times) were calculated. The normalized accumulated activities were then used with the software code OLINDA/EXM 1.1 to calculate the internal doses for the standard adult male and female models. Results: The mean effective dose was estimated to be 4.5 ± 0.3 μSv/MBq when all subjects were included and the male model was applied for the dosimetry calculation, and the mean effective dose was estimated to be 5.2 ± 0.2 μSv/MBq when the females were considered separately and the female model was applied for the calculation. The organ receiving the highest dose was the liver (17.9 ± 3.9 μSv/MBq), followed by the kidneys (14.3 ± 3.6 μSv/MBq) and the urinary bladder wall (13.5 ± 3.7 μSv/MBq). Conclusion: The estimated radiation doses for 11C-(+)-PHNO are similar to those reported for other radiotracers labeled with 11C. 11C-(+)-PHNO may be used for multiple PET scans in the same subject and remain within regulatory guidelines.
- Published
- 2012
5. Biodistribution and Radiation Dosimetry of the Serotonin 5-HT6 Ligand [11C]GSK215083 Determined from Human Whole-Body PET
- Author
-
William A. Hallett, Marc Laruelle, Robert A. Comley, Alvina Ng, Sylvain Houle, Alan A. Wilson, Nicholas Keat, Cristian Salinas, Irina Vitcu, Eugenii A. Rabiner, and Romina Mizrahi
- Subjects
Cancer Research ,Biodistribution ,medicine.diagnostic_test ,business.industry ,Equivalent dose ,Area under the curve ,Radiation ,Effective dose (radiation) ,Oncology ,Positron emission tomography ,medicine ,Dosimetry ,Radiology, Nuclear Medicine and imaging ,Serotonin ,business ,Nuclear medicine - Abstract
We measured the whole-body distribution of IV-injected [11C]GSK215083, a new 5-HT6 antagonist PET tracer, as a function of time in adult subjects, in order to determine the radiation exposure. After injection with a single bolus of [11C]GSK215083 (range 330–367 MBq; mean 346 MBq), PET emission data were acquired for approximately 120 min in six subjects (three males and three females). Five organs were identified as exhibiting uptake above background. For these, regions of interest were delineated on emission images, and time–activity curves (TAC) generated. Residence times were calculated as the area under the curve of the TAC, normalized to injected activities and standard values of organ volumes. Dosimetry calculations were then performed using the computer program OLINDA/EXM 1.0. The mean effective dose averaged over both males and females (±standard deviation) was estimated to be 7.7 ± 1.0 μSv/MBq (male 7.0 ± 0.4; female 8.5 ± 0.6). For the effective dose equivalent, the corresponding values are 7.8 ± 1.2 μSv/MBq (male 6.8 ± 0.5; female 8.9 ± 0.1). The organ receiving the highest dose was the lung, with an average equivalent dose of 25.6 ± 6.9 μSv/MBq (male 20.8 ± 5.6; female 30.4 ± 4.4). The estimated radiation dose for [11C]GSK215083 is consistent with those for other neuroreceptor ligands labeled with carbon-11. The somewhat higher dose estimate for females compared to males may reflect the difference in observed residence times and representative differences in the male and female phantoms used for dosimetry calculations. Based on conventionally accepted dose limits, [11C]GSK215083 may be used for multiple PET scans in the same subject.
- Published
- 2011
6. Quantitation of Translocator Protein Binding in Human Brain with the Novel Radioligand [18F]-FEPPA and Positron Emission Tomography
- Author
-
Peter M. Bloomfield, Pablo Rusjan, Irina Vitcu, Romina Mizrahi, Jeffrey H. Meyer, Sylvain Houle, and Alan A. Wilson
- Subjects
Adult ,Male ,Fluorine Radioisotopes ,Pyridines ,Coefficient of variation ,Young Adult ,Translocator protein ,medicine ,Radioligand ,Humans ,Anilides ,Aged ,biology ,medicine.diagnostic_test ,business.industry ,Chemistry ,Outcome measures ,Brain ,Binding potential ,Human brain ,Middle Aged ,medicine.anatomical_structure ,Neurology ,Positron emission tomography ,Positron-Emission Tomography ,biology.protein ,Original Article ,Female ,Neurology (clinical) ,Tomography ,Radiopharmaceuticals ,Cardiology and Cardiovascular Medicine ,Nuclear medicine ,business ,Protein Binding - Abstract
This article describes the kinetic modeling of [18F]-FEPPA binding to translocator protein 18 kDa in the human brain using high-resolution research tomograph (HRRT) positron emission tomography. Positron emission tomography scans were performed in 12 healthy volunteers for 180 minutes. A two-tissue compartment model (2-CM) provided, with no exception, better fits to the data than a one-tissue model. Estimates of total distribution volume ( VT), specific distribution volume ( VS), and binding potential ( BPND) demonstrated very good identifiability (based on coefficient of variation ( COV)) for all the regions of interest (ROIs) in the gray matter ( COV VT < 7%, COV VS < 8%, COV BPND < 11%). Reduction of the length of the scan to 2 hours is feasible as VS and VT showed only a small bias (6% and 7.5%, respectively). Monte Carlo simulations showed that, even under conditions of a 500% increase in specific binding, the identifiability of VT and VS was still very good with COVT values obtained from an unconstrained 2-CM with data from a 2-hour scan support the use of VT as an appropriate and feasible outcome measure for [18F]-FEPPA.
- Published
- 2011
7. Brain region binding of the D2/3 agonist [11C]-(+)-PHNO and the D2/3 antagonist [11C]raclopride in healthy humans
- Author
-
Philip Seeman, Irina Vitcu, Pablo Rusjan, Romina Mizrahi, David C. Mamo, Shitij Kapur, Ariel Graff-Guerrero, Nathalie Ginovart, Alan A. Wilson, and Matthaeus Willeit
- Subjects
Male ,Time Factors ,Dopamine ,Striatum ,ddc:616.89 ,Substantia Nigra/diagnostic imaging/metabolism ,Basal ganglia ,Radioligand ,Tissue Distribution ,Carbon Radioisotopes ,Receptors, Dopamine D2/agonists/metabolism ,Research Articles ,Raclopride ,Brain Mapping ,Dopamine Agonists/metabolism/pharmacokinetics ,Radiological and Ultrasound Technology ,Chemistry ,Putamen ,Substantia Nigra ,Dopamine D2 Receptor Antagonists ,Globus pallidus ,Neurology ,Dopamine Agonists ,Female ,Anatomy ,medicine.drug ,Adult ,Agonist ,medicine.medical_specialty ,Raclopride/metabolism/pharmacokinetics ,medicine.drug_class ,Globus Pallidus ,Binding, Competitive ,Binding, Competitive/drug effects/physiology ,Internal medicine ,Brain Mapping/methods ,Oxazines ,medicine ,Humans ,Radiology, Nuclear Medicine and imaging ,Corpus Striatum/diagnostic imaging/metabolism ,Globus Pallidus/diagnostic imaging/metabolism ,Neostriatum/diagnostic imaging/metabolism ,Receptors, Dopamine D2 ,Antagonist ,Positron-Emission Tomography/methods ,Dopamine Antagonists/metabolism/pharmacokinetics ,Corpus Striatum ,Dopamine/metabolism ,Neostriatum ,Endocrinology ,nervous system ,Positron-Emission Tomography ,Dopamine Antagonists ,Oxazines/metabolism/pharmacokinetics ,Neurology (clinical) ,Neuroscience - Abstract
The D(2) receptors exist in either the high‐ or low‐affinity state with respect to agonists, and while agonists bind preferentially to the high‐affinity state, antagonists do not distinguish between the two states. [(11)C]‐(+)‐PHNO is a PET D(2) agonist radioligand and therefore provides a preferential measure of the D(2) (high) receptors. In contrast, [(11)C]raclopride is an antagonist radioligand and thus binds with equal affinity to the D(2) high‐ and low‐affinity states. The aim was to compare the brain uptake, distribution and binding characteristics between [(11)C]‐(+)‐PHNO and [(11)C]raclopride in volunteers using a within‐subject design. Both radioligands accumulated in brain areas rich in D(2)/D(3)‐receptors. However, [(11)C]‐(+)‐PHNO showed preferential uptake in the ventral striatum and globus pallidus, while [(11)C]raclopride showed preferential uptake in the dorsal striatum. Mean binding potentials were higher in the putamen (4.3 vs. 2.8) and caudate (3.4 vs 2.1) for [(11)C]raclopride, equal in the ventral‐striatum (3.4 vs. 3.3), and higher in the globus pallidus for [(11)C]‐(+)‐PHNO (1.8 vs. 3.3). Moreover [(11)C]‐(+)‐PHNO kinetics in the globus pallidus showed a slower washout than other regions. One explanation for the preferential binding of [(11)C]‐(+)‐PHNO in the globus pallidus and ventral‐striatum could be the presence of a greater proportion of high‐ vs. low‐affinity receptors in these areas. Alternatively, the observed distribution could also be explained by a preferential binding of D(3)‐over‐D(2) with [(11)C]‐(+)‐PHNO. This differential binding of agonist vs. antagonist radioligand, especially in the critically important region of the limbic striatum/pallidum, offers new avenues to investigate the role of the dopamine system in health and disease. Hum Brain Mapp 2008. © 2007 Wiley‐Liss, Inc.
- Published
- 2008
8. Clinical improvement after treatment with VEGF165 in patients with severe chronic lower limb ischaemia
- Author
-
Raluca Iman, Catalin Marian, Adriana-Maria Neghina, Edward Seclaman, Bogdan Mut-Vitcu, Æ Stefan I. Dragulescu, Andrei Anghel, and Lorand Savu
- Subjects
medicine.medical_specialty ,medicine.medical_treatment ,Genetic enhancement ,chemistry.chemical_compound ,Gene therapy ,Text mining ,Internal medicine ,Genetics ,medicine ,Genetics(clinical) ,Adverse effect ,Saline ,Genetics (clinical) ,medicine.diagnostic_test ,business.industry ,Lower limb ischaemia ,Molecular medicine ,Surgery ,Vascular endothelial growth factor ,medicine.anatomical_structure ,chemistry ,Angiography ,Cardiology ,business ,Neo-vascularization ,Research Article ,Blood vessel - Abstract
The present study focuses on the application of a therapeutic strategy in patients with chronic severe lower limb ischaemia using a plasmid vector encoding the vascular endothelial growth factor (phVEGF165). It has been shown that VEGF promotes neo-vascularization and blood vessel network formation and thus might have the ability to improve blood-flow at the level of the affected limbs. However, little information is available regarding the necessary level of expression of VEGF and its possible related adverse effects. We have subcloned VEGF 165 isoform into pCMV-Script expression vector (Stratagene) under the control of the CMV promoter. Three patients with chronic ischaemia of the lower limb, considered as not suitable for surgical re-vascularization, received intramuscular injection with 0.5 ml saline solution containing 1011 copies of VEGF 165 plasmid. The clinical evolution has been monitored by angiography and estimated by walking time on the rolling carpet (Gardner protocol). Two months after therapy, all three patients showed complete relief of rest pain, improvement of ischaemic ulcer lesions and increased walking distance on the rolling carpet most probably due to appearance of newly formed collateral vessels.
- Published
- 2007
9. Separate brain regions code for salience vs. valence during reward prediction in humans
- Author
-
Irina Vitcu, Shitij Kapur, Jimmy Jensen, Adrian P. Crawley, Matthäus Willeit, David J. Mikulis, and Andrew J. A. Smith
- Subjects
Adult ,Male ,Conditioning, Classical ,Models, Neurological ,Choice Behavior ,Brain mapping ,Basal Ganglia ,Reward ,Salience (neuroscience) ,Basal ganglia ,Avoidance Learning ,medicine ,Humans ,Radiology, Nuclear Medicine and imaging ,Valence (psychology) ,Research Articles ,Brain Mapping ,Radiological and Ultrasound Technology ,Ventral striatum ,Magnetic Resonance Imaging ,medicine.anatomical_structure ,nervous system ,Neurology ,Incentive salience ,Female ,Orbitofrontal cortex ,Neurology (clinical) ,Anatomy ,Aversive Stimulus ,Psychology ,Neuroscience - Abstract
Predicting rewards and avoiding aversive conditions is essential for survival. Recent studies using computational models of reward prediction implicate the ventral striatum in appetitive rewards. Whether the same system mediates an organism's response to aversive conditions is unclear. We examined the question using fMRI blood oxygen level‐dependent measurements while healthy volunteers were conditioned using appetitive and aversive stimuli. The temporal difference learning algorithm was used to estimate reward prediction error. Activations in the ventral striatum were robustly correlated with prediction error, regardless of the valence of the stimuli, suggesting that the ventral striatum processes salience prediction error. In contrast, the orbitofrontal cortex and anterior insula coded for the differential valence of appetitive/aversive stimuli. Given its location at the interface of limbic and motor regions, the ventral striatum may be critical in learning about motivationally salient stimuli, regardless of valence, and using that information to bias selection of actions. Inc. Hum Brain Mapp, 2007. © 2006 Wiley‐Liss, Inc.
- Published
- 2007
10. Dicke-narrowed spectral line shapes of CO in Ar: Experimental results and a revised interpretation
- Author
-
A. D. May, Franck Thibault, James R. Drummond, Roman Ciuryło, Richard Wehr, and A. Vitcu
- Subjects
Physics ,Density matrix ,business.industry ,Inelastic collision ,Magnitude (mathematics) ,Noise (electronics) ,Atomic and Molecular Physics, and Optics ,Spectral line ,Spectral line shape ,Computational physics ,Optics ,Physical and Theoretical Chemistry ,business ,Constant (mathematics) ,Spectroscopy ,Line (formation) - Abstract
The shapes of Dicke-narrowed spectral lines in the fundamental P -branch of CO in Ar are studied by comparing high-resolution measurements and theoretical calculations. The measured spectra were recorded at temperatures between 214 and 324 K, and at pressures between 0.025 and 1 atm. The calculations are based on solving a transport/relaxation equation for the appropriate off-diagonal element of the density matrix; they use a realistic intermolecular potential to determine the speed-dependent collisional broadening, and a rigid sphere potential to determine the Dicke narrowing. It is found that the calculations can reproduce the measured spectra within the experimental noise under all conditions, but that the magnitude of the Dicke narrowing in the measured spectra is 70–90% less than predicted from the mass diffusion constant. A revised view of the collision operator resolves the discrepancy in principle, and leads to a better understanding of the line shape problem in general.
- Published
- 2006
11. Collisional line shifting and broadening in the fundamental P-branch of CO in Ar between 214 and 324K
- Author
-
Richard Wehr, Franck Thibault, James R. Drummond, A. Vitcu, and A. D. May
- Subjects
Physics ,Density matrix ,business.industry ,Power law ,Noise (electronics) ,Atomic and Molecular Physics, and Optics ,Spectral line ,Spectral line shape ,Optics ,Potential energy surface ,Rigid sphere ,Physical and Theoretical Chemistry ,Atomic physics ,business ,Spectroscopy ,Line (formation) - Abstract
The collisional shifts and widths of several P -branch spectral lines in the fundamental band of CO–Ar have been measured at temperatures between 214 and 324 K and pressures between 0.025 and 1 atm. The widths have been determined using a line shape model based on the solution of the transport/relaxation equation for the appropriate off-diagonal element of the density matrix. The model uses a realistic molecular potential energy surface to calculate the speed dependence of the collisional broadening, and a rigid sphere potential to calculate the translational motion. It is found that both the shifting and broadening coefficients follow a power law dependence on the temperature. Additionally, it is demonstrated that studies have tended to overestimate the accuracy of collisional widths when the line shape model used to obtain the widths involves multiple fitted line shape parameters or fails to fit the measured spectra within the experimental noise.
- Published
- 2006
12. Whole-body radiation dosimetry of 11C-carbonyl-URB694: a PET tracer for fatty acid amide hydrolase
- Author
-
Junchao Tong, Irina Vitcu, Pablo Rusjan, Romina Mizrahi, Isabelle Boileau, Alan A. Wilson, Asfandyar Mufti, Stephen J. Kish, Sylvain Houle, and Peter M. Bloomfield
- Subjects
Adult ,Male ,Amidohydrolases ,Image Processing, Computer-Assisted ,Medicine ,Humans ,Radiology, Nuclear Medicine and imaging ,In patient ,Tissue Distribution ,Whole Body Imaging ,Prospective Studies ,Pet tracer ,Radiometry ,Public Facility ,Border crossing ,business.industry ,Biphenyl Compounds ,Middle Aged ,medicine.disease ,Positron-Emission Tomography ,Female ,Medical emergency ,Carbamates ,Radiopharmaceuticals ,Nuclear medicine ,business ,Whole body ,Whole-Body Irradiation - Abstract
1993 Objectives To determine by a national survey: 1) the frequency of detection by public screening facilities of radioactivity in patients (pts) who had been treated with 131I for differentiated thyroid cancer (DTC), 2) the types and frequency of the various public facilities where pts were detected, and 3) the management of these pts by the security personnel. Methods Data were tabulated from a Thyroid Cancer Survivors Association, Inc. (ThyCa) website survey from November 2013 to December 2013 and was emailed to ~30,000 associates of ThyCa. Answers were tabulated of respondents (rpds) who reported that s/he 1) was >18 yo, 2) had at least one tx of 131I, and 3) was responding for his/her last 131I tx. The study was approved by the IRB. Results Of 334 rpds, 6.9% (23) attempted to pass through a public facility security checkpoint. Of these 23 pts all were detected and the detections occurred in an airport (7), border crossing (7), government building (3), shopping mall (3), train station (2), and steel recycling plant (1). The security personnel questioned 19 rpds, released 14 rpds without change in travel plans, rescanned 9 rpds, released 1 rpd with change in travel plans, and denied passage in 1 rpd. Security personnel verified the rpd’s 131I tx by examining an official document from the treating physician that was provided by 14 rpds, calling the treating facility regarding 3 rspds, and operating radiation detectors to identify the type and source of radiation in 2 rspds. Security personnel did not verify 131I tx in 4 rspds. Conclusions Public detection of radioactivity after 131I tx is infrequent, occurring in only 6.9% of respondents. Although airports and border crossings accounted for 61% of the sites of detection, the number of detected respondents was very low, and further respondents of the survey continue to be collected.
- Published
- 2014
13. Broadening, shifting, and line mixing in the 0310←0110 parallel Q branch of N2O
- Author
-
James R. Drummond, A. D. May, Richard Wehr, Roman Ciuryło, and A. Vitcu
- Subjects
Physics ,Absorption spectroscopy ,Spectrometer ,Infrared ,Band gap ,business.industry ,Inelastic collision ,Atomic and Molecular Physics, and Optics ,Pressure range ,Optics ,Medium pressure ,Relaxation matrix ,Physical and Theoretical Chemistry ,Atomic physics ,business ,Spectroscopy - Abstract
The 03 1 0 ← 01 1 0 parallel Q branch of N 2 O has been studied at 297 K and over the pressure range 1–130 torr. Absorption spectra were recorded using a high resolution (1.5 MHz or 5 × 10 −5 cm −1 ) and high signal-to-noise (>3500:1) mid-infrared spectrometer based on difference-frequency infrared generation in AgGaS 2 . In the low-pressure range (1–11 torr) we obtained accurate values for the line strengths, the broadening coefficients, the weak mixing coefficients, and the overall shifting of the branch. The medium pressure results, ranging from 23 to 130 torr, were analyzed by treating the band as a whole, using a relaxation matrix formalism, based on an energy gap scaling law. We find, effectively, that only 36% of the rotationally inelastic collisions are associated with Q branch mixing, the rest presumably being associated with Q – P and Q – R mixing in the same vibrational band. The pressure shifting coefficient of the 03 1 0 ← 01 1 0 Q branch as a whole was also determined and found to be 5.8 × 10 −3 cm −1 /atm towards lower frequencies.
- Published
- 2004
14. Broadening and line mixing in the 20 00←01 10, 11 10←00 00 and 12 20←01 10 Q branches of carbon dioxide: Experimental results and energy-corrected sudden modeling
- Author
-
A. Vitcu, James R. Drummond, Adriana Predoi-Cross, A. D. May, Christian Boulet, and Jean-Michel Hartmann
- Subjects
chemistry.chemical_classification ,Spectrometer ,Analytical chemistry ,General Physics and Astronomy ,Infrared spectroscopy ,Spectral line ,chemistry.chemical_compound ,chemistry ,Carbon dioxide ,Compounds of carbon ,Physical and Theoretical Chemistry ,Atomic physics ,Energy (signal processing) ,Mixing (physics) ,Line (formation) - Abstract
Using both a difference frequency spectrometer and a Fourier transform spectrometer, we have measured transitions in the 12 (2)0--01 (1)0 band of carbon dioxide at room temperature and pressures up to 19 atm. The low-pressure spectra were analyzed using a variety of standard spectral profiles, all with an asymmetric component to account for weak line mixing. For this band, we have been able to retrieve experimental line strengths and the broadening and weak mixing parameters. In this paper we also compare the suitability of the energy-corrected sudden model to predict mixing in the two previously measured Q branches 20 (0)0--01 (1)0, the 11 (1)0--00 (0)0, and the present Q branch of pure CO(2), all at room temperature.
- Published
- 2004
15. Improving cardiovascular prevention in patients with high cardiovascular risk through an innovative approach: 'The Coaching' care model
- Author
-
Andreea Dumitrescu, Roxana Pleava, O.C. Cosor, S. Mancas, Svetlana Mosteoru, L. Gaita, Dan Gaita, Kornelia Kotseva, Gabriela Mut-Vitcu, and David R. Wood
- Subjects
medicine.medical_specialty ,Cardiovascular prevention ,business.industry ,medicine ,In patient ,Medical emergency ,Cardiology and Cardiovascular Medicine ,medicine.disease ,business ,Intensive care medicine ,Coaching - Published
- 2016
16. Low body mass index analysis is associated with obstruction severity in chronic obstructive pulmonary disease patients in Romania
- Author
-
Roxana Pleava, Dan Gaita, Stefan Mihaicuta, Andreea Dumitrescu, L. Gaita, Gabriela Mut-Vitcu, Svetlana Mosteoru, Stefan Frentz, and Carmen Ardelean
- Subjects
medicine.medical_specialty ,business.industry ,Internal medicine ,medicine ,Cardiology ,Pulmonary disease ,Low body mass index ,Cardiology and Cardiovascular Medicine ,business ,Surgery - Published
- 2017
17. Lipid profile changes in a very high-risk cohort: Lessons from the EuroASPIRE database
- Author
-
L. Gaita, Kornelia Kotseva, Gabriela Mut-Vitcu, Roxana Pleava, Svetlana Mosteoru, Dan Gaita, David A. Wood, Andreea Dumitrescu, S. Mancas, and Oana Catalina Cosor
- Subjects
medicine.medical_specialty ,medicine.diagnostic_test ,business.industry ,Internal medicine ,Cohort ,Medicine ,Cardiology and Cardiovascular Medicine ,business ,Lipid profile ,Very high risk - Published
- 2017
18. The additional value of patient-reported health status in predicting 1-year mortality after invasive coronary procedures: a report from the Euro Heart Survey on Coronary Revascularisation
- Author
-
Lenzen M. J., Scholte Op Reimer W. J. M., Pedersen S. S., Boersma E., Maier W., Widimsky P., Simoons M. L., Mercado N. F., Wijns W., Bertrand M., Meier B., Sechtem U., Sergeant P., Stahle E., Unger F., Manini M., Bramley C., Laforest V., Taylor C., Del Gaiso S., Huber K., De Backer G., Sirakova V., Cerbak R., Thayssen P., Lehto S., Blanc J. -J., Delahaye F., Kobulia B., Zeymer U., Cokkinos D., Karlocai K., Graham I., Shelley E., Behar S., Maggioni A., Grabauskiene V., Deckers J., Asmussen I., Stepinska J., Goncalves L., Mareev V., Riecansky I., Kenda M. F., Alonso A., Lopez-Sendon J. L., Rosengren A., Buser P., Okay T., Sychov O., Fox K., Wood D., Crijns H., McGregor K., Mulder B., Priori S., Ryden L., Tavazzi L., Vahanian A., Vardas P., Sarkisyan K., Glogar H. D., Frick M., Pachinger O., Zwick R., Vrints C., Van Hertbruggen E., Vercammen M., Sysmans T., Schroeder E., Domange J., De Pril H., De Vriese J., Van Hecke T., Legrand V., Gillon M. -F., Richardy M., Doneux P., Petrov I., Jorgova J., Starcevic B., Eeckhout E., Berger A., Prudent V., Camenzind E., Masson N., Zambartas C., Kleanthous H., Stellova B., Aschermann M., Simek S., Kautzner J., Karmazin V., Svab P., Indrak J., Branny M., Hladilova K., Kala P., Cappelen H., Jensen L. O., Gitt A., Gehrke K., am Rhein L., Erbel R., Gutersohn A., Eggebrecht H., Al Khani M., Rosenberger A., Vogelsberg H., Klepzig H., Schmidt A., Silber S., Mau B., Leuner C., Czyborra K., Reuschling C., Muno E., Nauheim B., Kleber F., Rux S., Saad A., Elabady M., Beiras A. C., Fernandez J. S., del Arno F. N., Romo A. I., Fernandez J. M. C., Mayoreal A. R., Rebanal F. J. R., de la Borbolla M. G., Chaparro M., Brotons C., Miralda C. P., Vila i Perez S. I., Moris C., Aviles F. F., de la Fuente Galan L., Vinuela P. T., de Torres F. M., Mora J., Rodriguez I. S., Bustamante I. P., Fernandez P. L. S., Torrent J. L. D., Diez Gil J. L., Perpinan J., Motilla V. P., Juango M. S. A., Berjon-Reyero J., Moreno R. M., Guerrero J. C. F., Savolainen K., Syvanne M., Cohen-Solal A., Oboa A. -S., Bassand J. P., Espinosa D. P., Jouet V., Cedex B., Montalescot G., Gallois V., Daubert J. C., Clerc J. M., Machecourt J., Cottin Y., Walker D., Holland F., Prosser J., Muir L., Barber K., Cleland J. G. F., Cook J., Chapichadze Z., Christos I. S. A., Tsiavou N., Chrysohoou C., Manginas A., Terrovitis J., Kanakakis J., Vavuranakis M., Drakos S., Farmakis T., Samara C., Papakosta C., Bourantas C., Michalis L. K., Christos M., Foussas S., Adamopoulou E., Vardas P. E., Marketou M., Alotti N., Basa A. M., Vigh A., Preda I., Csoti E., Keltai M., Kerkovits G., Hendler A., Blatt A., Yakov B., Beyar R., Shefer A., Halon D., Bentzvi M., Avramovitch N., Bakst A., Saba K., Cafri C., Grosbard A., Sheva B., Margolis B., Suleiman K., Banai S., Meerkin D., Mosseri M., Guita P., Jabara R., Jafari J., Shitrit D. B., Ghasan Salameh, Brezins M., van den Akker-Berman L., Guetta V., Hashomer T., Rozenman Y., Biagini A., Berti S., Ferrero M., Colombo A., Roccaforte R., Milici C., Scarpino L., Salvi A., Desideri A., Sabbadin D., Veneto C., Galassi A., Giuffrida G., Rognoni A., Vassanelli C., Paffoni P., Cioppa A., Rubino P., de Carlo M., Petronio A. S., Naccarella F., Saia F., Marzocchi A., Maranga S. S., Presbitero P., Valsecchi F., Piscione F., Esposito G., Santini N. M., Tubaro M., Erglis A., Narbute I., Kavoliuniene A., Zaliunas R., Navickas R., Luckute D., Subkovas E., Wagner D., Vermeer F., Lousberg A., Fransen H., Breeman A., Tebbe H., De Boer M. J., van der Wal M., Vos J., Leenders C. M., Veerhoek M. J., Jansen C., Bijl M., Koppelaar C., den Linden V., Brons R., Widdershofen J. W. M. G., Broers H., Kontny F., Jonzon M., Wodniecki J., Tomasik A., Trusz-Gluza M., Nowak S., Ruzyllo W., Deptuch T., Marques J., Matias F., Madeira H., Oliveira J., Sargento L., Ionac A., Dragulescu I. S., Mut-Vitcu B., Maximov D., Dorobantu M., Apetrei E., Niculescu R., Petrescu V., Bucsa A., Deleanu D., Bucharest, Benedek I. S., Hintea T., Aronov D., Tikhomirova E., Kranjec I., Prokselj K., Kanic V., Sepetoglu A., Aytekin S., Aytekin V., Catakoglu A. B., Parlar H., Tufekcioglu S., Ozyedek Z., Baltali M., Kiziltan D., Vukovic M., Neskovic A. N., Cardiology, Lenzen, M. J., Scholte Op Reimer, W. J. M., Pedersen, S. S., Boersma, E., Maier, W., Widimsky, P., Simoons, M. L., Mercado, N. F., Wijns, W., Bertrand, M., Meier, B., Sechtem, U., Sergeant, P., Stahle, E., Unger, F., Manini, M., Bramley, C., Laforest, V., Taylor, C., Del Gaiso, S., Huber, K., De Backer, G., Sirakova, V., Cerbak, R., Thayssen, P., Lehto, S., Blanc, J. -J., Delahaye, F., Kobulia, B., Zeymer, U., Cokkinos, D., Karlocai, K., Graham, I., Shelley, E., Behar, S., Maggioni, A., Grabauskiene, V., Deckers, J., Asmussen, I., Stepinska, J., Goncalves, L., Mareev, V., Riecansky, I., Kenda, M. F., Alonso, A., Lopez-Sendon, J. L., Rosengren, A., Buser, P., Okay, T., Sychov, O., Fox, K., Wood, D., Crijns, H., Mcgregor, K., Mulder, B., Priori, S., Ryden, L., Tavazzi, L., Vahanian, A., Vardas, P., Sarkisyan, K., Glogar, H. D., Frick, M., Pachinger, O., Zwick, R., Vrints, C., Van Hertbruggen, E., Vercammen, M., Sysmans, T., Schroeder, E., Domange, J., De Pril, H., De Vriese, J., Van Hecke, T., Legrand, V., Gillon, M. -F., Richardy, M., Doneux, P., Petrov, I., Jorgova, J., Starcevic, B., Eeckhout, E., Berger, A., Prudent, V., Camenzind, E., Masson, N., Zambartas, C., Kleanthous, H., Stellova, B., Aschermann, M., Simek, S., Kautzner, J., Karmazin, V., Svab, P., Indrak, J., Branny, M., Hladilova, K., Kala, P., Cappelen, H., Jensen, L. O., Gitt, A., Gehrke, K., am Rhein, L., Erbel, R., Gutersohn, A., Eggebrecht, H., Al Khani, M., Rosenberger, A., Vogelsberg, H., Klepzig, H., Schmidt, A., Silber, S., Mau, B., Leuner, C., Czyborra, K., Reuschling, C., Muno, E., Nauheim, B., Kleber, F., Rux, S., Saad, A., Elabady, M., Beiras, A. C., Fernandez, J. S., del Arno, F. N., Romo, A. I., Fernandez, J. M. C., Mayoreal, A. R., Rebanal, F. J. R., de la Borbolla, M. G., Chaparro, M., Brotons, C., Miralda, C. P., Vila i Perez, S. I., Moris, C., Aviles, F. F., de la Fuente Galan, L., Vinuela, P. T., de Torres, F. M., Mora, J., Rodriguez, I. S., Bustamante, I. P., Fernandez, P. L. S., Torrent, J. L. D., Diez Gil, J. L., Perpinan, J., Motilla, V. P., Juango, M. S. A., Berjon-Reyero, J., Moreno, R. M., Guerrero, J. C. F., Savolainen, K., Syvanne, M., Cohen-Solal, A., Oboa, A. -S., Bassand, J. P., Espinosa, D. P., Jouet, V., Cedex, B., Montalescot, G., Gallois, V., Daubert, J. C., Clerc, J. M., Machecourt, J., Cottin, Y., Walker, D., Holland, F., Prosser, J., Muir, L., Barber, K., Cleland, J. G. F., Cook, J., Chapichadze, Z., Christos, I. S. A., Tsiavou, N., Chrysohoou, C., Manginas, A., Terrovitis, J., Kanakakis, J., Vavuranakis, M., Drakos, S., Farmakis, T., Samara, C., Papakosta, C., Bourantas, C., Michalis, L. K., Christos, M., Foussas, S., Adamopoulou, E., Vardas, P. E., Marketou, M., Alotti, N., Basa, A. M., Vigh, A., Preda, I., Csoti, E., Keltai, M., Kerkovits, G., Hendler, A., Blatt, A., Yakov, B., Beyar, R., Shefer, A., Halon, D., Bentzvi, M., Avramovitch, N., Bakst, A., Saba, K., Cafri, C., Grosbard, A., Sheva, B., Margolis, B., Suleiman, K., Banai, S., Meerkin, D., Mosseri, M., Guita, P., Jabara, R., Jafari, J., Shitrit, D. B., Ghasan, Salameh, Brezins, M., van den Akker-Berman, L., Guetta, V., Hashomer, T., Rozenman, Y., Biagini, A., Berti, S., Ferrero, M., Colombo, A., Roccaforte, R., Milici, C., Scarpino, L., Salvi, A., Desideri, A., Sabbadin, D., Veneto, C., Galassi, A., Giuffrida, G., Rognoni, A., Vassanelli, C., Paffoni, P., Cioppa, A., Rubino, P., de Carlo, M., Petronio, A. S., Naccarella, F., Saia, F., Marzocchi, A., Maranga, S. S., Presbitero, P., Valsecchi, F., Piscione, F., Esposito, G., Santini, N. M., Tubaro, M., Erglis, A., Narbute, I., Kavoliuniene, A., Zaliunas, R., Navickas, R., Luckute, D., Subkovas, E., Wagner, D., Vermeer, F., Lousberg, A., Fransen, H., Breeman, A., Tebbe, H., De Boer, M. J., van der Wal, M., Vos, J., Leenders, C. M., Veerhoek, M. J., Jansen, C., Bijl, M., Koppelaar, C., den Linden, V., Brons, R., Widdershofen, J. W. M. G., Broers, H., Kontny, F., Jonzon, M., Wodniecki, J., Tomasik, A., Trusz-Gluza, M., Nowak, S., Ruzyllo, W., Deptuch, T., Marques, J., Matias, F., Madeira, H., Oliveira, J., Sargento, L., Ionac, A., Dragulescu, I. S., Mut-Vitcu, B., Maximov, D., Dorobantu, M., Apetrei, E., Niculescu, R., Petrescu, V., Bucsa, A., Deleanu, D., Bucharest, Benedek, I. S., Hintea, T., Aronov, D., Tikhomirova, E., Kranjec, I., Prokselj, K., Kanic, V., Sepetoglu, A., Aytekin, S., Aytekin, V., Catakoglu, A. B., Parlar, H., Tufekcioglu, S., Ozyedek, Z., Baltali, M., Kiziltan, D., Vukovic, M., and Neskovic, A. N.
- Subjects
Male ,medicine.medical_specialty ,Epidemiology ,medicine.medical_treatment ,Health Status ,Coronary Artery Disease ,Revascularization ,Coronary artery disease ,Cohort Studies ,Risk Factors ,Surveys and Questionnaires ,medicine ,Myocardial Revascularization ,Surveys and Questionnaire ,Humans ,Prospective Studies ,Prospective cohort study ,Aged ,business.industry ,Risk Factor ,Mortality rate ,Confounding ,Middle Aged ,medicine.disease ,Surgery ,Europe ,Prospective Studie ,Treatment Outcome ,Emergency medicine ,Population study ,Female ,Cohort Studie ,Cardiology and Cardiovascular Medicine ,business ,Human ,Cohort study - Abstract
Objective: Self-perceived health status may be helpful in identifying patients at high risk for adverse outcomes. The Euro Heart Survey on Coronary Revascularization (EHS-CR) provided an opportunity to explore whether impaired health status was a predictor of 1-year mortality in patients with coronary artery disease (CAD) undergoing angiographic procedures. Methods: Data from the EHS-CR that included 5619 patients from 31 member countries of the European Society of Cardiology were used. Inclusion criteria for the current study were completion of a self-report measure of health status, the EuroQol Questionnaire (EQ-5D) at discharge and information on 1-year follow-up, resulting in a study population of 3786 patients. Results: The 1-year mortality was 3.2% (n = 120). Survivors reported fewer problems on the five dimensions of the EQ-5D as compared with non-survivors. A broad range of potential confounders were adjusted for, which reached a p
- Published
- 2006
19. Patients enrolled in coronary intervention trials are not representative of patients in clinical practice: results from the Euro Heart Survey on Coronary Revascularization
- Author
-
Hordijk-Trion M., Lenzen M., Wijns W., De Jaegere P., Simoons M. L., Scholte Op Reimer W. J. M., Bertrand M. E., Mercado N., Boersma E., Maier W., Meier B., Moris C., Piscione F., Sechtem U., Sergeant P., Stahle E., Vos J., Widimsky P., Unger F., Manini M., Bramley C., Laforest V., Taylor C., Del Gaiso S., Huber K., De Backer G., Sirakova V., Cerbak R., Thayssen P., Lehto S., Blanc J. -J., Delahaye F., Kobulia B., Zeymer U., Cokkinos D., Karlocai K., Graham I., Shelley E., Behar S., Maggioni A., Grabauskiene V., Deckers J., Asmussen I., Stepinska J., Goncalves L., Mareev V., Riecansky I., Kenda M. F., Alonso A., Lopez-Sendon J. L., Rosengren A., Buser P., Okay T., Sychov O., Fox K., Wood D., Crijns H., McGregor K., Mulder B., Priori S., Ryden L., Tavazzi L., Vahanian A., Vardas P., Sarkisyan K., Glogar H. D., Frick M., Pachinger O., Zwick R., Vrints C., Van Hertbruggen E., Vercammen M., Sysmans T., Schroeder E., Domange J., De Pril H., De Vriese J., Van Hecke T., Legrand V., Gillon M. -F., Richardy M., Doneux P., Petrov I., Jorgova J., Starcevic B., Eeckhout E., Berger A., Prudent V., Camenzind E., Masson N., Zambartas C., Kleanthous H., Stellova B., Aschermann M., Simek S., Kautzner J., Karmazin V., Svab P., Indrak J., Branny M., Hladilova K., Kala P., Cappelen H., Jensen L. O., Gitt A., Gehrke K., am Rhein L., Erbel R., Gutersohn A., Eggebrecht H., Al Khani M., Rosenberger A., Vogelsberg H., Klepzig H., Schmidt A., Silber S., Mau B., Leuner C., Czyborra K., Reuschling C., Muno E., Nauheim B., Kleber F., Rux S., Saad A., Elabady M., Beiras A. C., Fernandez J. S., del Arno F. N., Romo A. I., Fernandez J. M. C., Mayoreal A. R., Rebanal F. J. R., de la Borbolla M. G., Chaparro M., Brotons C., Miralda C. P., Vila i Perez S. I., Aviles F. F., de la Fuente Galan L., Vinuela P. T., de Torres F. M., Mora J., Rodriguez I. S., Bustamante I. P., Fernandez P. L. S., Torrent J. L. D., Gil J. L. D., Perpinan J., Motilla V. P., Juango M. S. A., Berjon-Reyero J., Moreno R. M., Guerrero J. C. F., Savolainen K., Syvanne M., Cohen-Solal A., Oboa A. -S., Bassand J. P., Espinosa D. P., Jouet V., Cedex B., Montalescot G., Gallois V., Daubert J. C., Clerc J. M., Machecourt J., Cottin Y., Walker D., Holland F., Prosser J., Muir L., Barber K., Cleland J. G. F., Cook J., Chapichadze Z., Christos I. S. A., Tsiavou N., Chrysohoou C., Manginas A., Terrovitis J., Kanakakis J., Vavuranakis M., Drakos S., Farmakis T., Samara C., Papakosta C., Bourantas C., Michalis L. K., Christos M., Foussas S., Adamopoulou E., Marketou M., Alotti N., Basa A. M., Vigh A., Preda I., Csoti E., Keltai M., Kerkovits G., Hendler A., Blatt A., Yakov B., Beyar R., Shefer A., Halon D., Bentzvi M., Avramovitch N., Bakst A., Saba K., Cafri C., Grosbard A., Sheva B., Margolis B., Suleiman K., Banai S., Meerkin D., Mosseri M., Guita P., Jabara R., Jafari J., Shitrit D. B., Ghasan D., Salameh D., Brezins M., van den Akker-Berman L., Guetta V., Hashomer T., Rozenman Y., Biagini A., Berti S., Ferrero M., Colombo A., Roccaforte R., Milici C., Scarpino L., Salvi A., Desideri A., Sabbadin D., Veneto C., Galassi A., Giuffrida G., Rognoni A., Vassanelli C., Paffoni P., Cioppa A., Rubino P., de Carlo M., Petronio A. S., Naccarella F., Saia F., Marzocchi A., Maranga S. S., Presbitero P., Valsecchi F., Esposito G., Santini N. M., Tubaro M., Erglis A., Narbute I., Kavoliuniene A., Zaliunas R., Navickas R., Luckute D., Subkovas E., Wagner D., Vermeer F., Lousberg A., Fransen H., Breeman A., Tebbe H., De Boer M. J., van der Wal M., Leenders C. M., Veerhoek M. J., Jansen C., Bijl M., Koppelaar C., den Linden V., Brons R., Widdershofen J. W. M. G., Broers H., Kontny F., Jonzon M., Wodniecki J., Tomasik A., Trusz-Gluza M., Nowak S., Ruzyllo W., Deptuch T., Marques J., Matias F., Madeira H., Oliveira J., Sargento L., Ionac A., Dragulescu I. S., Mut-Vitcu B., Maximov D., Dorobantu M., Apetrei E., Niculescu R., Petrescu V., Bucsa A., Deleanu D., Bucharest, Benedek I. S., Hintea T., Aronov D., Tikhomirova E., Kranjec I., Prokselj K., Kanic V., Sepetoglu A., Aytekin S., Aytekin V., Catakoglu A. B., Parlar H., Tufekcioglu S., Ozyedek Z., Baltali M., Kiziltan, Vukovic M., Neskovic A. N., Cardiology, Hordijk-Trion, M., Lenzen, M., Wijns, W., De Jaegere, P., Simoons, M. L., Scholte Op Reimer, W. J. M., Bertrand, M. E., Mercado, N., Boersma, E., Maier, W., Meier, B., Moris, C., Piscione, F., Sechtem, U., Sergeant, P., Stahle, E., Vos, J., Widimsky, P., Unger, F., Manini, M., Bramley, C., Laforest, V., Taylor, C., Del Gaiso, S., Huber, K., De Backer, G., Sirakova, V., Cerbak, R., Thayssen, P., Lehto, S., Blanc, J. -J., Delahaye, F., Kobulia, B., Zeymer, U., Cokkinos, D., Karlocai, K., Graham, I., Shelley, E., Behar, S., Maggioni, A., Grabauskiene, V., Deckers, J., Asmussen, I., Stepinska, J., Goncalves, L., Mareev, V., Riecansky, I., Kenda, M. F., Alonso, A., Lopez-Sendon, J. L., Rosengren, A., Buser, P., Okay, T., Sychov, O., Fox, K., Wood, D., Crijns, H., Mcgregor, K., Mulder, B., Priori, S., Ryden, L., Tavazzi, L., Vahanian, A., Vardas, P., Sarkisyan, K., Glogar, H. D., Frick, M., Pachinger, O., Zwick, R., Vrints, C., Van Hertbruggen, E., Vercammen, M., Sysmans, T., Schroeder, E., Domange, J., De Pril, H., De Vriese, J., Van Hecke, T., Legrand, V., Gillon, M. -F., Richardy, M., Doneux, P., Petrov, I., Jorgova, J., Starcevic, B., Eeckhout, E., Berger, A., Prudent, V., Camenzind, E., Masson, N., Zambartas, C., Kleanthous, H., Stellova, B., Aschermann, M., Simek, S., Kautzner, J., Karmazin, V., Svab, P., Indrak, J., Branny, M., Hladilova, K., Kala, P., Cappelen, H., Jensen, L. O., Gitt, A., Gehrke, K., am Rhein, L., Erbel, R., Gutersohn, A., Eggebrecht, H., Al Khani, M., Rosenberger, A., Vogelsberg, H., Klepzig, H., Schmidt, A., Silber, S., Mau, B., Leuner, C., Czyborra, K., Reuschling, C., Muno, E., Nauheim, B., Kleber, F., Rux, S., Saad, A., Elabady, M., Beiras, A. C., Fernandez, J. S., del Arno, F. N., Romo, A. I., Fernandez, J. M. C., Mayoreal, A. R., Rebanal, F. J. R., de la Borbolla, M. G., Chaparro, M., Brotons, C., Miralda, C. P., Vila i Perez, S. I., Aviles, F. F., de la Fuente Galan, L., Vinuela, P. T., de Torres, F. M., Mora, J., Rodriguez, I. S., Bustamante, I. P., Fernandez, P. L. S., Torrent, J. L. D., Gil, J. L. D., Perpinan, J., Motilla, V. P., Juango, M. S. A., Berjon-Reyero, J., Moreno, R. M., Guerrero, J. C. F., Savolainen, K., Syvanne, M., Cohen-Solal, A., Oboa, A. -S., Bassand, J. P., Espinosa, D. P., Jouet, V., Cedex, B., Montalescot, G., Gallois, V., Daubert, J. C., Clerc, J. M., Machecourt, J., Cottin, Y., Walker, D., Holland, F., Prosser, J., Muir, L., Barber, K., Cleland, J. G. F., Cook, J., Chapichadze, Z., Christos, I. S. A., Tsiavou, N., Chrysohoou, C., Manginas, A., Terrovitis, J., Kanakakis, J., Vavuranakis, M., Drakos, S., Farmakis, T., Samara, C., Papakosta, C., Bourantas, C., Michalis, L. K., Christos, M., Foussas, S., Adamopoulou, E., Marketou, M., Alotti, N., Basa, A. M., Vigh, A., Preda, I., Csoti, E., Keltai, M., Kerkovits, G., Hendler, A., Blatt, A., Yakov, B., Beyar, R., Shefer, A., Halon, D., Bentzvi, M., Avramovitch, N., Bakst, A., Saba, K., Cafri, C., Grosbard, A., Sheva, B., Margolis, B., Suleiman, K., Banai, S., Meerkin, D., Mosseri, M., Guita, P., Jabara, R., Jafari, J., Shitrit, D. B., Ghasan, D., Salameh, D., Brezins, M., van den Akker-Berman, L., Guetta, V., Hashomer, T., Rozenman, Y., Biagini, A., Berti, S., Ferrero, M., Colombo, A., Roccaforte, R., Milici, C., Scarpino, L., Salvi, A., Desideri, A., Sabbadin, D., Veneto, C., Galassi, A., Giuffrida, G., Rognoni, A., Vassanelli, C., Paffoni, P., Cioppa, A., Rubino, P., de Carlo, M., Petronio, A. S., Naccarella, F., Saia, F., Marzocchi, A., Maranga, S. S., Presbitero, P., Valsecchi, F., Esposito, G., Santini, N. M., Tubaro, M., Erglis, A., Narbute, I., Kavoliuniene, A., Zaliunas, R., Navickas, R., Luckute, D., Subkovas, E., Wagner, D., Vermeer, F., Lousberg, A., Fransen, H., Breeman, A., Tebbe, H., De Boer, M. J., van der Wal, M., Leenders, C. M., Veerhoek, M. J., Jansen, C., Bijl, M., Koppelaar, C., den Linden, V., Brons, R., Widdershofen, J. W. M. G., Broers, H., Kontny, F., Jonzon, M., Wodniecki, J., Tomasik, A., Trusz-Gluza, M., Nowak, S., Ruzyllo, W., Deptuch, T., Marques, J., Matias, F., Madeira, H., Oliveira, J., Sargento, L., Ionac, A., Dragulescu, I. S., Mut-Vitcu, B., Maximov, D., Dorobantu, M., Apetrei, E., Niculescu, R., Petrescu, V., Bucsa, A., Deleanu, D., Bucharest, Benedek, I. S., Hintea, T., Aronov, D., Tikhomirova, E., Kranjec, I., Prokselj, K., Kanic, V., Sepetoglu, A., Aytekin, S., Aytekin, V., Catakoglu, A. B., Parlar, H., Tufekcioglu, S., Ozyedek, Z., Baltali, M., Kiziltan, Vukovic, M., and Neskovic, A. N.
- Subjects
Male ,medicine.medical_specialty ,Randomization ,medicine.medical_treatment ,Euro Heart Survey ,Coronary Artery Disease ,Revascularization ,law.invention ,Coronary artery disease ,Randomized controlled trial ,law ,Internal medicine ,Angioplasty ,medicine ,Humans ,cardiovascular diseases ,Angioplasty, Balloon, Coronary ,Coronary Artery Bypass ,CABG ,Aged ,Randomized Controlled Trials as Topic ,business.industry ,Coronary Artery Bypa ,Patient Selection ,PCI ,Health Survey ,Middle Aged ,medicine.disease ,Health Surveys ,Surgery ,Clinical trial ,Stenosis ,surgical procedures, operative ,Clinical Trials, Phase III as Topic ,Conventional PCI ,Female ,Cardiology and Cardiovascular Medicine ,business ,Human - Abstract
Aims: Revascularization in patients with coronary artery disease changed over the last two decades, favouring the number of patients treated by means of percutaneous coronary interventions (PCI) when compared with coronary artery bypass grafting (CABG). Many randomized controlled trials (RCTs) have been performed to compare these two competing revascularization techniques. Because of the strict enrolment criteria of RCTs in which highly selected patients are recruited, the applicability of the results may be limited in clinical practice. The current study evaluates to what extent patients in clinical practice were similar to those who participated in RCTs comparing PCI with CABG. Methods and results: Clinical characteristics and 1-year outcome of 4713 patients enrolled in the Euro Heart Survey on Coronary Revascularization were compared with 8647 patients who participated in 14 major RCTs, comparing PCI with CABG. In addition, we analysed which proportion of survey patients would have disqualified for trial participation (n = 3033, 64%), aiming at identifying differences between trial-eligible and trial-ineligible survey patients. In general, important differences were observed between trial participants and survey patients. Patients in clinical practice were older, more often had comorbid conditions, single-vessel disease, and left main stem stenosis when compared with trial participants. Almost identical differences were observed between trial-eligible and trial-ineligible survey patients. In clinical practice, PCI was the treatment of choice, even in patients who were trial-ineligible (46% PCI, 26% CABG, 28% medical). PCI remained the preferred treatment option in patients with multi-vessel disease (57% in trial-eligible and 40% in trial-ineligible patients, respectively, P < 0.001); yet, the risk profile of patients treated by PCI was better than that for patients treated either by CABG or by medical therapy. In the RCTs, there was no mortality difference between PCI and CABG. In clinical practice, however, we observed 1-year unadjusted survival benefit for PCI vs. CABG (2.9 vs. 5.4%, P < 0.001). Survival benefit was only observed in trial-ineligible patients (3.3 vs. 6.2%, P < 0.001). Conclusion: Many patients in clinical practice were not represented in RCTs. Moreover, only 36% of these patients were considered eligible for participating in a trial comparing PCI with CABG. We demonstrated that RCTs included younger patients with a better cardiovascular risk profile when compared with patients in everyday clinical practice. This study highlights the disparity between patients in clinical practice and patients in whom the studies that provide the evidence for treatment guidelines are performed. © The European Society of Cardiology 2006. All rights reserved.
- Published
- 2006
20. PT083 'Coaching' Care Model – An Innovative Method to Improve Cardiovascular Prevention in Patients With High Cardiovascular Risk
- Author
-
Svetlana Mosteoru, David A. Wood, Andreea Dumitrescu, Kornelia Kotseva, O.C. Cosor, S. Mancas, Gabriela Mut-Vitcu, Roxana Pleava, L. Gaita, and Dan Gaita
- Subjects
Community and Home Care ,medicine.medical_specialty ,Cardiovascular prevention ,Epidemiology ,business.industry ,medicine ,Physical therapy ,In patient ,Cardiology and Cardiovascular Medicine ,Intensive care medicine ,business ,Coaching - Published
- 2016
21. Whole body biodistribution and radiation dosimetry in humans of a new PET ligand, [(18)F]-FEPPA, to image translocator protein (18 kDa)
- Author
-
Romina Mizrahi, Sylvain Houle, Irina Vitcu, Pablo Rusjan, Alvina Ng, Peter M. Bloomfield, and Alan A. Wilson
- Subjects
Adult ,Male ,Cancer Research ,Biodistribution ,Pyridines ,Whole body imaging ,Ligands ,Receptors, GABA ,Translocator protein ,medicine ,Dosimetry ,Humans ,Radiology, Nuclear Medicine and imaging ,Anilides ,Tissue Distribution ,Whole Body Imaging ,Radiometry ,biology ,medicine.diagnostic_test ,business.industry ,Chemistry ,Oncology ,Internal dose ,Positron emission tomography ,Organ Specificity ,Positron-Emission Tomography ,Pet ligand ,biology.protein ,Female ,Whole body ,Nuclear medicine ,business - Abstract
[(18)F]-FEPPA is a translocator protein (18 kDa, TSPO) positron emission tomography (PET) radiotracer. Radiation dosimetry was estimated from the whole body biodistribution, taking into consideration TSPO rs6971 (Ala147Thr) polymorphism.[(18)F]-FEPPA whole body PET scans were acquired for six healthy subjects. Time-activity curves were generated from regions of interest of nine organs, from which normalized accumulated activities were calculated and thus internal dose, using OLINDA/EXM 1.1. Genotyping of rs6971, associated with high- and low-affinity [(18)F]-FEPPA binding (high-affinity binder (HAB) and low-affinity binder (LAB)), was performed.Five subjects exhibited the C/C (HAB) allele, and the other carried the minor allele T/T (LAB). The LAB whole body biodistribution showed highest radioactivity accumulation in bladder, whereas in HABs, the spleen received the highest dose. The effective dose of the single LAB (16.3 μSv/MBq) was 23 % less than the mean of the HABs (21.0 ± 2.9 μSv/MBq). When including all subjects, the effective dose was 20.2 ± 3.0 μSv/MBq.[(18)F]-FEPPA radiation dose is consistent with other (18)F-labeled radioligands and the Ala147Thr genotype agreed with [(18)F]-FEPPA distribution.
- Published
- 2012
22. Genetic technologies in cancer investigation - applications in aggresive lymphoid malignancies
- Author
-
Nicoleta Mariana, Berbec, Aurora, Arghir, Anca, Vitcu, Silvana, Angelescu, Andrei, Colita Amd, Anca, Ciobanu, Sorina Mihaela, Papuc, Andreea-Cristina, Tutlan-Cunita, and Anca Roxana, Lupu
- Subjects
State of the Art - Published
- 2012
23. Biodistribution and radiation dosimetry of the serotonin 5-HT₆ ligand [¹¹C]GSK215083 determined from human whole-body PET
- Author
-
Robert A, Comley, Cristian, Salinas, Romina, Mizrahi, Irina, Vitcu, Alvina, Ng, William, Hallett, Nicholas, Keat, Alan A, Wilson, Eugenii A, Rabiner, Marc, Laruelle, and Sylvain, Houle
- Subjects
Adult ,Male ,Time Factors ,Adolescent ,Dose-Response Relationship, Radiation ,Ligands ,Young Adult ,Organ Specificity ,Positron-Emission Tomography ,Receptors, Serotonin ,Injections, Intravenous ,Quinolines ,Humans ,Female ,Tissue Distribution ,Whole Body Imaging ,Carbon Radioisotopes ,Sulfones ,Radiometry - Abstract
We measured the whole-body distribution of IV-injected [¹¹C]GSK215083, a new 5-HT₆ antagonist PET tracer, as a function of time in adult subjects, in order to determine the radiation exposure.After injection with a single bolus of [¹¹C]GSK215083 (range 330-367 MBq; mean 346 MBq), PET emission data were acquired for approximately 120 min in six subjects (three males and three females). Five organs were identified as exhibiting uptake above background. For these, regions of interest were delineated on emission images, and time-activity curves (TAC) generated. Residence times were calculated as the area under the curve of the TAC, normalized to injected activities and standard values of organ volumes. Dosimetry calculations were then performed using the computer program OLINDA/EXM 1.0.The mean effective dose averaged over both males and females (deviation) was estimated to be 7.7 ± 1.0 μSv/MBq (male 7.0 ± 0.4; female 8.5 ± 0.6). For the effective dose equivalent, the corresponding values are 7.8 ± 1.2 μSv/MBq (male 6.8 ± 0.5; female 8.9 ± 0.1). The organ receiving the highest dose was the lung, with an average equivalent dose of 25.6 ± 6.9 μSv/MBq (male 20.8 ± 5.6; female 30.4 ± 4.4).The estimated radiation dose for [¹¹C]GSK215083 is consistent with those for other neuroreceptor ligands labeled with carbon-11. The somewhat higher dose estimate for females compared to males may reflect the difference in observed residence times and representative differences in the male and female phantoms used for dosimetry calculations. Based on conventionally accepted dose limits, [¹¹C]GSK215083 may be used for multiple PET scans in the same subject.
- Published
- 2011
24. Side effects profile in humans of (11)C-(+)-PHNO, a dopamine D(2/3) agonist ligand for PET
- Author
-
Sylvain Houle, Alvina Ng, Alan A. Wilson, Irina Vitcu, and Romina Mizrahi
- Subjects
Agonist ,medicine.diagnostic_test ,Chemistry ,medicine.drug_class ,Stereochemistry ,Ligand ,Receptors, Dopamine D2 ,Receptors, Dopamine D3 ,Ligands ,Positron emission tomography ,Dopamine receptor D2 ,Positron-Emission Tomography ,Pet ligand ,Oxazines ,medicine ,Humans ,Regression Analysis ,Radiology, Nuclear Medicine and imaging ,Selectivity ,Receptor - Abstract
TO THE EDITOR: 11C-(+)-4-propyl-9-hydroxynaphthoxazine ((+)-PHNO) is a new PET ligand developed by our group. Binding assays show that (+)-PHNO displays high affinity and selectivity for the D2 receptor ( [1][1] ). Recently, it has been noted that 11C-(+)-PHNO has a preferential affinity and
- Published
- 2010
25. Adverse subjective experience with antipsychotics and its relationship to striatal and extrastriatal D2 receptors—a PET study in schizophrenia
- Author
-
Ariel Graff, Shitij Kapur, Ofer Agid, David C. Mamo, Irina Vitcu, Robert B. Zipursky, I. Vitcu, Romina Mizrahi, and Pablo Rusjan
- Subjects
medicine.medical_specialty ,Neurology ,business.industry ,Schizophrenia ,Cognitive Neuroscience ,Dopamine receptor D2 ,Medicine ,business ,Psychiatry ,medicine.disease ,Clinical psychology - Published
- 2006
26. Unusual Cause of Heart Failure in a 65-Year-Old Woman
- Author
-
Mirela Cleopatra Tomescu, Mioara Cocora, Adelina Mavrea, Dan Rusinaru, Ioana Citu, Bogdan Mut-Vitcu, and Stefan Iosif Dragulescu M.D.
- Subjects
medicine.medical_specialty ,Angina ,Pseudoaneurysm ,Internal medicine ,medicine ,Humans ,Radiology, Nuclear Medicine and imaging ,cardiovascular diseases ,Myocardial infarction ,Heart Aneurysm ,Aged ,Ultrasonography ,Heart Failure ,Mitral regurgitation ,business.industry ,Cardiac Rupture ,Mitral Valve Insufficiency ,medicine.disease ,Surgery ,Cardiac surgery ,Heart failure ,Infective endocarditis ,cardiovascular system ,Cardiology ,Female ,Tomography, X-Ray Computed ,Cardiology and Cardiovascular Medicine ,business - Abstract
Left ventricular (LV) free wall rupture is a potentially lethal mechanical complication after myocardial infarction (MI). Pericardial adhesions or slow extracardiac leak and pericardial inflammation may result in a contained cardiac rupture. LV pseudoaneurysm is a relatively uncommon clinical entity. It may occur after MI, but also as a complication of infective endocarditis, cardiac surgery, or trauma. Patients developing LV pseudoaneurysm after MI may present angina pectoris or signs of congestive heart failure (HF) but often are asymptomatic. Surgery is the treatment of choice for LV pseudoaneurysms diagnosed in the first months after MI. The management of chronic LV pseudoaneurysms is still subject of debate. This report highlights a 65-year-old patient newly hospitalized for acute decompensated HF who was diagnosed with a large chronic LV pseudoaneurysm and severe mitral regurgitation. The patient underwent successful resection of the pseudoaneurysm and patch repair of the ruptured ventricular wall.
- Published
- 2008
27. Quetiapine extended-release versus immediate-release formulation: a positron emission tomography study
- Author
-
Hiroyuki Uchida, Irina Vitcu, Penny Barsoum, Shitij Kapur, Alain Gendron, Jeffrey M. Goldstein, and David C. Mamo
- Subjects
Adult ,Male ,Dibenzothiazepines ,Adolescent ,medicine.drug_class ,Atypical antipsychotic ,Pharmacology ,Trough (economics) ,Hypnotic ,Quetiapine Fumarate ,Pharmacokinetics ,medicine ,Humans ,Dosing ,Cross-Over Studies ,Receptors, Dopamine D2 ,Middle Aged ,Crossover study ,Corpus Striatum ,Diagnostic and Statistical Manual of Mental Disorders ,Psychiatry and Mental health ,Pharmacodynamics ,Delayed-Action Preparations ,Positron-Emission Tomography ,Schizophrenia ,Female ,Antipsychotic Agents - Abstract
OBJECTIVE: The pharmacokinetic and pharmacodynamic profile of the immediate-release (IR) formulation of quetiapine is characterized by a rapid peak in plasma level and striatal dopamine D(2) receptor occupancy, followed by a rapid decrease to baseline levels, necessitating the use of twice-daily dosing. An extended-release (XR) formulation of quetiapine is currently being developed to achieve similar efficacy using a once-daily dosing regimen. We compared the central D(2) receptor binding between the IR and XR formulations. METHOD: In this open-label, crossover positron emission tomography study using [(11)C]-raclopride, we compared the central D(2) receptor binding potential at expected peak and trough plasma levels using equivalent daily doses of the IR and XR formulations (300, 600, and 800 mg/day) in 12 subjects. Data were collected from April 2002 to May 2003. RESULTS: The mean plasma level of quetiapine at trough was significantly lower than that at peak for all dose groups of both formulations except for IR 300 and 800 mg (all p values < .05), while the mean plasma level did not differ significantly between formulations at trough and peak. The mean occupancy at peak was significantly higher than that at trough for all dose groups other than IR 800 mg/day (all p values < .05) and did not differ significantly between formulations at trough and peak. CONCLUSION: Once-daily dosing of the XR formulation gives peak and trough plasma levels and central D(2) receptor occupancy comparable to twice-daily dosing of the IR formulation. These data should be considered while determining equivalent doses, as well as switching strategies.
- Published
- 2008
28. First human evidence of d-amphetamine induced displacement of a D2/3 agonist radioligand: A [11C]-(+)-PHNO positron emission tomography study
- Author
-
Ariel Graff, Matthäus Willeit, Nathalie Ginovart, Alan A. Wilson, Irina Vitcu, Pablo Rusjan, Philip Seeman, Sylvain Houle, and Shitij Kapur
- Subjects
Agonist ,Adult ,Male ,medicine.medical_specialty ,Dextroamphetamine ,medicine.drug_class ,Globus Pallidus ,chemistry.chemical_compound ,ddc:616.89 ,Dopamine ,Internal medicine ,Oxazines ,medicine ,Radioligand ,Humans ,Amphetamine ,Neurotransmitter ,Corpus Striatum/diagnostic imaging/metabolism ,Putamen/diagnostic imaging/metabolism ,Globus Pallidus/diagnostic imaging/metabolism ,Pharmacology ,Dopamine Agonists/chemical synthesis ,Chemistry ,Dextroamphetamine/pharmacology ,Putamen ,Brain ,Corpus Striatum ,Oxazines/chemical synthesis ,Psychiatry and Mental health ,Endocrinology ,Globus pallidus ,Positron-Emission Tomography ,Dopamine Agonists ,Catecholamine ,Caudate Nucleus/diagnostic imaging/metabolism ,Female ,Caudate Nucleus ,Brain/diagnostic imaging/metabolism ,medicine.drug - Abstract
Imaging the competition between D(2/3) radioligands and endogenous dopamine is so far the only way to measure dopamine release in the living human brain. The dopamine D(2) receptor exists in a high (D(2)(high)) and a low-affinity state for dopamine. Under physiological conditions, dopamine is expected to bind to D(2)(high) only. [(11)C]-(+)-4-propyl-9-hydroxynaphthoxazine ((+)-PHNO) is the first D(2/3) agonist radioligand for positron emission tomography (PET) imaging in humans. Since [(11)C]-(+)-PHNO is expected to bind preferentially to D(2)(high), it should be particularly vulnerable to competition with endogenous dopamine. Nine healthy subjects participated in two PET scans, one after administration of d-amphetamine and one after placebo. [(11)C]-(+)-PHNO PET test re-test variability was determined in 11 healthy subjects. Binding potentials (BPs) were calculated for caudate, putamen, ventral striatum, and globus pallidus. d-Amphetamine led to a significant decrease of [(11)C]-(+)-PHNO BPs in caudate (-13.2%), putamen (-20.8%), and ventral striatum (-24.9%), but not in globus pallidus (-6.5%). d-Amphetamine-induced displacement correlated with serum d-amphetamine levels in all regions but caudate. This is the first report on competition between endogenous dopamine and a D(2/3) agonist radioligand in humans. [(11)C]-(+)-PHNO PET might be a superior measure for release of endogenous dopamine than PET employing conventional D(2/3) antagonist radioligands.
- Published
- 2007
29. Temporal difference modeling of the blood-oxygen level dependent response during aversive conditioning in humans: effects of dopaminergic modulation
- Author
-
Ariel Graff-Guerrero, Shitij Kapur, Adrian P. Crawley, Mahesh Menon, Mark A. Smith, Jimmy Jensen, and Irina Vitcu
- Subjects
Adult ,Male ,Time Factors ,Adolescent ,Dopamine ,Conditioning, Classical ,behavioral disciplines and activities ,Dopamine Uptake Inhibitors ,Neural Pathways ,medicine ,Image Processing, Computer-Assisted ,Humans ,Amphetamine ,Biological Psychiatry ,Blood-oxygen-level dependent ,Putamen ,Ventral striatum ,Ventral Tegmental Area ,Classical conditioning ,Galvanic Skin Response ,Middle Aged ,Magnetic Resonance Imaging ,Electric Stimulation ,Ventral tegmental area ,Oxygen ,Substantia Nigra ,medicine.anatomical_structure ,Globus pallidus ,nervous system ,Dopamine Antagonists ,Haloperidol ,Female ,Psychology ,Neuroscience ,Reinforcement, Psychology ,psychological phenomena and processes ,medicine.drug - Abstract
Background The prediction error (PE) hypothesized by the temporal difference model has been shown to correlate with the phasic activity of dopamine neurons during reward learning and the blood-oxygen level dependent (BOLD) response during reward and aversive conditioning tasks. We hypothesized that dopamine would modulate the PE related signal in aversive conditioning and that haloperidol would reduce PE related activity, while an acute dose of amphetamine would increase PE related activity in the ventral striatum. Methods Healthy participants took an acute dose of amphetamine, haloperidol, or placebo. We used functional magnetic resonance imaging (fMRI) to measure the BOLD signal while they carried out an aversive conditioning task, using cutaneous electrical stimulation as the unconditioned stimulus (US) and yellow and blue circles as conditioned stimulus (CS+ and CS−, respectively). Results Prediction error related BOLD activity was seen only in the ventral striatum in the placebo subjects. The subjects given amphetamine showed a wider network of PE related BOLD activity, including the ventral striatum, globus pallidus, putamen, insula, anterior cingulate, and substantia nigra/ventral tegmental area. Haloperidol subjects did not show PE related activity in any of these regions. Conclusions Our results provide the first demonstration that the modulation of dopamine transmission affects both the physiological correlates and PE related BOLD activity during aversive learning.
- Published
- 2006
30. An automated method for the extraction of regional data from PET images
- Author
-
Irina Vitcu, Douglas Hussey, Suhara Tetsuya, Sylvain Houle, David C. Mamo, Pablo Rusjan, Nathalie Ginovart, Fumihiko Yasuno, and Shitij Kapur
- Subjects
Computer science ,Neuroscience (miscellaneous) ,Models, Biological ,Software ,Region of interest ,medicine ,Brain positron emission tomography ,Humans ,Radiology, Nuclear Medicine and imaging ,Segmentation ,Image analysis ,Temporal cortex ,Reproducibility ,Electronic Data Processing ,medicine.diagnostic_test ,business.industry ,Brain ,Reproducibility of Results ,Pattern recognition ,Magnetic Resonance Imaging ,Psychiatry and Mental health ,Positron emission tomography ,Positron-Emission Tomography ,Artificial intelligence ,business ,Nuclear medicine - Abstract
Manual drawing of regions of interest (ROIs) on brain positron emission tomography (PET) images is labour intensive and subject to intra- and inter-individual variations. To standardize analysis and improve the reproducibility of PET measures, we have developed image analysis software for automated quantification of PET data. The method is based on the individualization of a set of standard ROIs using a magnetic resonance (MR) image co-registered with the PET image. To evaluate the performance of this automated method, the software-based quantification has been compared with conventional manual quantification of PET images obtained using three different PET radiotracers: [ 11 C]-WAY 100635, [ 11 C]-raclopride and [ 11 C]-DASB. Our results show that binding potential estimates obtained using the automated method correlate highly with those obtained by trained raters using manual delineation of ROIs for frontal and temporal cortex, thalamus, and striatum (global intraclass correlation coefficient > 0.8). For the three radioligands, the software yields time–activity data that are similar (within 8%) to those obtained by manual quantification, eliminates investigator-dependent variability, considerably shortens the time required for analysis and thus provides an alternative method for accurate quantification of PET data.
- Published
- 2005
31. Inflammatory response after dexamethasone eluting coronary stent implantation
- Author
-
B, Mut-Vitcu, S I, Drăgulescu, Andreea, Drăgulescu, A, El Kahlout, Adriana, Coroban, Daniela, Maximov, and M, Slovenski
- Subjects
Inflammation ,Male ,Anti-Inflammatory Agents ,Coronary Disease ,Middle Aged ,Dexamethasone ,C-Reactive Protein ,Drug Delivery Systems ,Treatment Outcome ,Risk Factors ,Humans ,Female ,Stents ,Prospective Studies - Abstract
C-reactive protein (CRP) elevation after coronary stent implantation is a predictor for recurrence. We prospectively evaluated the inflammatory response after dexamethasone eluting stent implantation in a native coronary artery by serial measurement of plasma level C-reactive protein.We investigated patients undergoing primary successful implantation of a single dexamethasone stent (Dexamet, Abbott Vascular Devices, Redwood City, CA, USA) in a native coronary artery. We analyzed plasma concentrations of CRP by immunoturbidimetric assay before stent implantation and 12, 24, 48 and 72 hours after the procedure. Patients on anti-inflammatory drugs or with evidences of inflammatory conditions were excluded.Seventeen patients (mean age 62+/-9 years, 12 males) were enrolled. The presentation was unstable angina in 13 patients and stable angina in 4 patients. Eighteen stents were implanted as follows: 16 type B lesions (88%), 1 type C lesions (6%) and 1 type A lesion (6%), located in LM in 2 patients (11%), LAD in 8 (44%), LCX/OM in 7 (39%), and RCA in 1 patient (6%). The mean CRP increased from 5.6+/-2.2 mg/l at baseline to a maximum of 6.7+/-2.1 mg/l and than decreased to 5.0+/-1.2 mg/l at 72 hours. At 72 hours plasma concentration of CRP was lower than baseline in 11 patients (65%) and higher in 6 (35%).Inflammatory response to dexamethasone stent implantation in a native coronary artery is low and peaks at 24 hours. At 72 hours after stent implantation, mean CRP decreased comparing with baseline, CRP becoming lower in 65% patients. Using the stent itself as a platform for drug delivery may be an opportunity to modulate the inflammatory response to coronary stent implantation.
- Published
- 2004
32. High-resolution tunable mid-infrared spectrometer based on difference-frequency generation in AgGaS2
- Author
-
A. Vitcu, James R. Drummond, Roman Wehr, Richard Ciurylo, and A. David May
- Subjects
Dye laser ,Materials science ,Spectrometer ,business.industry ,Infrared ,Materials Science (miscellaneous) ,Industrial and Manufacturing Engineering ,Spectral line ,Rhodamine 6G ,Crystal ,Laser linewidth ,chemistry.chemical_compound ,Optics ,chemistry ,Optoelectronics ,Business and International Management ,business ,Line (formation) - Abstract
We have built a high-resolution and high-signal-to-noise ratio spectrometer for line shape studies of greenhouse gases in the mid infrared. The infrared radiation is generated in a AgGaS2 nonlinear crystal by the well-known difference-frequency method. The choice of crystal is explained, and a brief literature review is presented. With two tunable dye lasers and a type I, 90 degrees phase-matching geometry, the infrared is continuously tunable from 7 to 9 microm when Rhodamine 6G and Sulforhodamine 640 dyes are used. The total infrared power exceeds 30 nW and is limited by both the damage threshold and thermal loading of the crystal. Phase-sensitive detection allows us to reach signal-to-noise ratios in excess of 3500:1 while maintaining an instrumental linewidth of 1.5 MHz. However, we show that the spectrometer may be used to measure the positions of spectral lines within +/-400 kHz.
- Published
- 2004
33. Dynamic spectroscopic measurements of the temperature and pressure cycles in a MOPITT pressure modulator cell
- Author
-
Roman Ciuryło, A. Vitcu, Richard Wehr, James R. Drummond, and Eamonn McKernan
- Subjects
Materials science ,business.industry ,Materials Science (miscellaneous) ,Analytical chemistry ,Temperature measurement ,Industrial and Manufacturing Engineering ,MOPITT ,Spectral line ,law.invention ,Troposphere ,Pressure measurement ,Optics ,law ,Temporal resolution ,Radiometry ,Business and International Management ,business ,Remote sensing ,Line (formation) - Abstract
The temperature and pressure cycles inside a pressure modulator cell (PMC) of the type used for gas-correlation radiometry aboard the Measurements of Pollution in the Troposphere (MOPITT) satellite instrument have been determined from dynamic measurements of the spectral line shapes of the R(0) and R(18) transitions in the fundamental vibrational-rotational band of carbon monoxide. The line strengths and linewidths were used to calculate the temperature and pressure, respectively, with a temporal resolution of approximately 200 micros, or 1/100 of a PMC cycle. The results are compared with a thermodynamic box model.
- Published
- 2003
34. Spectral line shape of theP(2)transition in CO-Ar: Uncorrelatedab initiocalculation
- Author
-
A. Vitcu, James R. Drummond, Franck Thibault, Richard Wehr, A. D. May, and Roman Ciuryło
- Subjects
Physics ,Argon ,chemistry ,Ab initio ,chemistry.chemical_element ,Translational motion ,Visible radiation ,Atomic physics ,Atomic and Molecular Physics, and Optics ,Uncorrelated ,Coherence (physics) ,Spectral line shape - Abstract
We calculate the spectral line shape of an isolated line from first principles, assuming that the translational motion is not statistically correlated with the evolution of the optical coherence, i.e., with the broadening. We use the known, realistic potentials for the influence of collisions on the translational motion and on the internal motion. We show that the calculated profiles do not agree, particularly at low pressures, with very precise experimental profiles of the P(2) line of CO in a bath of Ar. We establish that the source of the disagreement lies in the assumption of uncorrelated effects of collisions on the translational motion and the optical coherence associated with the internal degrees of freedom.
- Published
- 2002
35. High Resolution and High Signal-to-Noise Measurements in the 0310 ← 0110 Q-Branch of N2O at 1160 cm−1
- Author
-
A. D. May, James R. Drummond, Roman Ciuryło, Richard Wehr, and A. Vitcu
- Subjects
Spectrometer ,Chemistry ,Torr ,Resolution (electron density) ,Analytical chemistry ,Plasma diagnostics ,Atomic physics ,Order of magnitude ,Spectral line ,Noise (radio) ,Line (formation) - Abstract
High‐resolution measurements of the Π ← Π Q‐branch of pure N2O near 1160 cm−1 were made using a difference‐frequency spectrometer with resolution of 5 × 10−5 cm−1 and a signal‐to‐noise ratio of 2000:1. Lines Q18F through Q12E have been recorded in a single scan, at room temperature and at pressures ranging from 1 to 130 torr. The spectra are analyzed up to 23 torr on a line‐by‐line basis using a hard collision profile including Dicke narrowing and line mixing. Since the separation of the central lines of this double‐sided Q‐branch is of the same order of magnitude with the collisional broadening, line mixing is considered in the analysis even at 1 torr and its dependence with pressure is studied.
- Published
- 2002
36. Comparison of an ab initio calculation of the CO-Ar P(2) line shape with high-resolution measurements
- Author
-
Franck Thibault, Richard Wehr, A. Vitcu, Roman Ciuryło, James R. Drummond, and A. D. May
- Subjects
Argon ,chemistry ,Ab initio quantum chemistry methods ,Master equation ,Intermolecular force ,Ab initio ,chemistry.chemical_element ,Molecule ,Plasma diagnostics ,Physics::Chemical Physics ,Atomic physics ,Spectral line - Abstract
A practical matrix‐based formalism for solving the master equation for a spectral line is applied to the P(2) transition in the fundamental band of carbon monoxide perturbed by argon. The method assumes that the effect of intermolecular collisions on the internal relaxation of the molecules is uncorrelated with the effect of those collisions on the translational motion of the molecules. Comparison with high‐resolution line shape measurements reveals that at low pressures, the omission of statistical correlation leads to a miscalculation of the shape of the line.
- Published
- 2002
37. Laser-plasma harmonics with high-contrast pulses and designed prepulses
- Author
-
H. Higaki, S. P. Le Blanc, G. Kulcsar, A. Vitcu, R. Wagner, Robin Marjoribanks, L. Zhao, F.W. Budnik, Anatoly Maksimchuk, Michael C. Downer, and Donald P. Umstadter
- Subjects
Chemistry ,business.industry ,Physics::Optics ,Plasma ,Breakup ,Laser ,law.invention ,Harmonic spectrum ,Optics ,Physics::Plasma Physics ,law ,Harmonics ,Picosecond ,High harmonic generation ,Plasma diagnostics ,business - Abstract
One aspect of the complexity of mid- and high-harmonic generation in high-intensity laser-plasma interactions is that nonlinear hydrodynamics is virtually always folded together with the nonlinear optical conversion process. We have partly dissected this issue in picosecond and subpicosecond interactions with preformed plasma gradients, imaging and spectrally resolving low- and mid-order harmonics. We describe spatial breakup of the picosecond beam in preformed plasmas, concomitant broadening and breakup of the harmonic spectrum, presumably through self-phase modulation, together with data on the sensitivity of harmonics production efficiency to the gradient or extent of preformed plasma. Lastly, we show preliminary data of regular Stokes-like and anti-Stokes-like satellites to the harmonics, accompanied by modification of the forward-scattered beam.
- Published
- 1998
38. Systemic nanoparticle albumin-bound paclitaxel (nab-paclitaxel) for the prevention of in-stent restenosis (SNAPIST-II): a randomized comparison of single dose and single dose plus repeat dose at 2 months
- Author
-
F. Ortan, S. Rush, B. Mut-Vitcu, C. Dima, I. Benedek, P. Klinke, M. Dorobantu, T. Hintea, S. Mot, Ron Waksman, N. Desai, J.E. MacDonald, A. Clawson, Anthony Fung, D. Hilton, S.M. Balanescu, R. Niculescu, D. Ricci, R. Capalneanu, J. Margolis, M. Ursu, and C. Suciu
- Subjects
medicine.medical_specialty ,Albumin bound paclitaxel ,business.industry ,Urology ,medicine ,General Medicine ,In stent restenosis ,Cardiology and Cardiovascular Medicine ,business ,Repeat dose ,Nab-paclitaxel - Published
- 2006
39. Continuing Medical Education Program in Echocardiography
- Author
-
Pohoey Fan, Mirela Tomescu, Dan Rusinaru, Bogdan Mut-Vitcu, Mioara Cocora, Adelina Mavrea, Ioana Citu, and Stefan Iosif Dragulescu
- Subjects
Radiology, Nuclear Medicine and imaging ,Cardiology and Cardiovascular Medicine - Published
- 2008
40. Erratum to 'Dicke-narrowed spectral line shapes of CO in Ar: Experimental results and a revised interpretation' [J. Mol. Spectrosc. 235 (2006) 54–68]
- Author
-
Franck Thibault, Richard Wehr, James R. Drummond, A. Vitcu, A. D. May, and Roman Ciuryło
- Subjects
Physics ,Quantum mechanics ,Line (geometry) ,Limit (mathematics) ,Physical and Theoretical Chemistry ,Spectroscopy ,Atomic and Molecular Physics, and Optics ,Spectral line ,Collision rate ,Interpretation (model theory) - Abstract
The publisher regrets that some corrections requested by the author at the proof stage were not made. On page 57, the first full sentence under Eq. (10) should read: ‘‘Unlike Eq. (8), Eq. (9) leads to a line shape with the correct behaviour in the limit as the velocity-changing collision rate goes to zero.’’ On page 58, lines 9 and 10 under the Section 3 heading should read: ‘‘. . . (see, for example, [4, 38, 42, 43, 49, 51, 52]).. . .’’
- Published
- 2006
41. Effects of d-amphetamine on binding of the new D2/3 receptor agonist radioligand [11C]-(+)-PHNO in humans
- Author
-
Ariel Graff, Sylvain Houle, Pablo Rusjan, Nathalie Ginovart, Irina Vitcu, Alan A. Wilson, Matthaeus Willeit, Shitij Kapur, and Peter M. Bloomfield
- Subjects
Agonist ,Neurology ,medicine.drug_class ,Chemistry ,Cognitive Neuroscience ,Radioligand ,medicine ,Pharmacology ,Receptor ,Amphetamine ,medicine.drug - Published
- 2006
42. Positron emission tomography quantification of [11C]-(+)-PHNO binding to the dopamine D2/D3 receptors in the human brain
- Author
-
Ariel Graff, Irina Vitcu, Alan A. Wilson, Matthaeus Willeit, Nathalie Ginovart, Sylvain Houle, Pablo Rusjan, Shitij Kapur, and Peter M. Bloomfield
- Subjects
Nuclear magnetic resonance ,medicine.anatomical_structure ,Neurology ,medicine.diagnostic_test ,Positron emission tomography ,Chemistry ,Cognitive Neuroscience ,Dopamine receptor D2 ,medicine ,Brain positron emission tomography ,Human brain ,Receptor - Published
- 2006
43. Validation of a method for automatic quantification of radioactivity in the globus pallidus in [11C]-(+)-PHNO PET images
- Author
-
Ariel Graff, Pablo MartínRusjan, Matthaeus Willeit, Nathalie Ginovart, Shitij Kapur, Irina Vitcu, Sylvain Houle, and Romina Mizrahi
- Subjects
Globus pallidus ,Neurology ,Chemistry ,business.industry ,Cognitive Neuroscience ,Nuclear medicine ,business - Published
- 2006
44. Moxonidine therapy in cirrhotic portal hypertension
- Author
-
Mihnea Străin, Radu Strain, Bogdan Mut-Vitcu, and Stefan Iosif Dragulescu
- Subjects
medicine.medical_specialty ,Moxonidine ,Hepatology ,business.industry ,Portal venous pressure ,Internal medicine ,Cardiology ,Medicine ,Portal hypertension ,business ,medicine.disease ,medicine.drug - Published
- 2002
45. Simanschi, Leon, ed. Petru Rareş. Bucharest: Editura Academiei Republicii Socialiste România, 1978. Pp. 336
- Author
-
Dumitru Vitcu
- Subjects
History - Published
- 1984
46. Dicke-narrowed line shapes in CO-Ar: Measurements, calculations, and a revised interpretation
- Author
-
W.-K. Liu, Richard Wehr, D. A. Shapiro, Roman Ciuryło, James R. Drummond, Franck Thibault, F. R. W. McCourt, A. Vitcu, and A. D. May
- Subjects
Density matrix ,Range (particle radiation) ,Classical mechanics ,Spectrometer ,Chemistry ,Relaxation (physics) ,Kinetic energy ,Quantum ,Interpretation (model theory) ,Computational physics ,Line (formation) - Abstract
New line shape calculations for CO buffered by Ar are compared to high‐resolution measurements from a difference‐frequency laser spectrometer, over a range of thermodynamic conditions relevant to the atmosphere. The calculations are based on solving the quantum kinetic (i.e. transport/relaxation) equation for the molecules within the impact approximation, and rely on the commonly used MOLSCAT and MOLCOL codes to determine the speed‐dependent collisional relaxation rate. Velocity‐changing effects are treated classically using a rigid sphere potential. The comparison initially reveals that the experimental profiles exhibit only 10% to 30% of the expected Dicke narrowing, which leads us to reevaluate our understanding of the narrowing process. A more subtle aspect of the disagreement between theory and experiment draws our attention to an assumption implicit in the calculation of the collisional relaxation rate: the assumption of a Maxwellian form for the velocity dependence of the off‐diagonal elements of the density matrix (i.e. the optical coherences). This assumption allows for an analytical simplification of the problem, but eliminates velocity‐changing effects (so that they must be added back in using a supplementary classical calculation, which is based here on a rigid sphere interaction). We find that the removal of the above‐mentioned assumption should allow for accurate and fully quantum mechanical (but numerical) line shape calculations for systems like CO‐Ar on existing computers.
47. Spectral line shape of the P(2) transition in CO-Ar: Uncorrelated ab initio calculation
- Author
-
Wehr, R., Vitcu, A., Roman Ciurylo, Thibault, F., Drummond, J. R., and May, A. D.
48. Diplomatii unirii
- Author
-
Frederick Kellogg and Dumitru Vitcu
- Subjects
Archeology ,History ,Museology - Published
- 1980
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.